Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

1.

Singer M, Deutschman CS, Seymour CW et al (2016) The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810PubMedPubMedCentralCrossRef

2.

Fleischmann C, Scherag A, Adhikari NK et al (2016) Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 193(3):259–272PubMedCrossRef

3.

Fleischmann-Struzek C, Mellhammar L, Rose N et al (2020) Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med 46(8):1552–1562PubMedPubMedCentralCrossRef

4.

Rhee C, Dantes R, Epstein L et al (2017) Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA 318(13):1241–1249PubMedPubMedCentralCrossRef

5.

Seymour CW, Liu VX, Iwashyna TJ et al (2016) Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):762–774PubMedPubMedCentralCrossRef

6.

Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4):1250–1256PubMedCrossRef

7.

Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39(2):165–228PubMedPubMedCentralCrossRef

8.

Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41(2):580–637PubMedCrossRef

9.

Dellinger RP, Carlet JM, Masur H et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32(3):858–873PubMedCrossRef

10.

Dellinger RP, Levy MM, Carlet JM (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 (vol 36, pg 296, 2008). Crit Care Med 36(4):1394–1396

11.

Dellinger RP, Levy MM, Carlet JM et al (2008) surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36(1):296–327PubMedCrossRef

12.

Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486–552PubMedCrossRef

13.

Rhodes A, Evans LE, Alhazzani W et al (2017) surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377PubMedCrossRef

14.

Weiss SL, Peters MJ, Alhazzani W et al (2020) Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med 46(Suppl 1):10–67PubMedPubMedCentralCrossRef

15.

Weiss SL, Peters MJ, Alhazzani W et al (2020) Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med 21(2):e52–e106PubMedCrossRef

16.

Guyatt GH, Oxman AD, Kunz R et al (2011) GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64(4):395–400PubMedCrossRef

17.

Akl EA, Johnston BC, Alonso-Coello P et al (2013) Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers. PLoS One 8(2):e57132PubMedPubMedCentralCrossRef

18.

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188PubMedCrossRef

19.

Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924–926PubMedPubMedCentralCrossRef

20.

Balshem H, Helfand M, Schunemann HJ et al (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64(4):401–406PubMedCrossRef

21.

Andrews J, Guyatt G, Oxman AD et al (2013) GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 66(7):719–725PubMedCrossRef

22.

Guyatt GH, Oxman AD, Santesso N et al (2013) GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol 66(2):158–172PubMedCrossRef

23.

Schunemann HJ, Wiercioch W, Brozek J et al (2017) GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. J Clin Epidemiol 81:101–110PubMedCrossRef

24.

Guyatt GH, Schunemann HJ, Djulbegovic B et al (2015) Guideline panels should not GRADE good practice statements. J Clin Epidemiol 68(5):597–600PubMedCrossRef

25.

Dellinger RP (2015) The future of sepsis performance improvement. Crit Care Med 43(9):1787–1789

26.

Schorr C, Odden A, Evans L et al (2016) Implementation of a multicenter performance improvement program for early detection and treatment of severe sepsis in general medical–surgical wards. J Hosp Med 11(S1):S32–S39PubMedCrossRef

27.

Damiani E, Donati A, Serafini G et al (2015) Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS One 10(5):e0125827PubMedPubMedCentralCrossRef

28.

Alberto L, Marshall AP, Walker R et al (2017) Screening for sepsis in general hospitalized patients: a systematic review. J Hosp Infect 96(4):305–315PubMedCrossRef

29.

Bhattacharjee P, Edelson DP, Churpek MM (2017) Identifying patients with sepsis on the hospital wards. Chest 151(4):898–907PubMedCrossRef

30.

Makam AN, Nguyen OK, Auerbach AD (2015) Diagnostic accuracy and effectiveness of automated electronic sepsis alert systems: a systematic review. J Hosp Med 10(6):396–402PubMedCrossRef

31.

Warttig S, Alderson P, Evans DJ et al (2018) Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients. Cochrane Database oSyste Rev. 6(6):CD012404-CD

32.

Islam MM, Nasrin T, Walther BA et al (2019) Prediction of sepsis patients using machine learning approach: a meta-analysis. Comput Methods Programs Biomed 170:1–9PubMedCrossRef

33.

Downing NL, Rolnick J, Poole SF et al (2019) Electronic health record-based clinical decision support alert for severe sepsis: a randomised evaluation. BMJ Qual Saf 28(9):762–768PubMedPubMedCentralCrossRef

34.

Hooper MH, Weavind L, Wheeler AP et al (2012) Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit*. Crit Care Med 40(7):2096–2101PubMedPubMedCentralCrossRef

35.

Shimabukuro DW, Barton CW, Feldman MD et al (2017) Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: a randomised clinical trial. BMJ Open Respir Res 4(1):e000234PubMedPubMedCentralCrossRef

36.

Rao TSS, Radhakrishnan R, Andrade C (2011) Standard operating procedures for clinical practice. Indian J Psychiatry 53(1):1–3PubMedPubMedCentralCrossRef

37.

Osborn TM (2017) Severe sepsis and septic shock trials (ProCESS, ARISE, ProMISe): what is optimal resuscitation? Crit Care Clin 33(2):323–344PubMedCrossRef

38.

Kahn JM, Davis BS, Yabes JG et al (2019) Association between state-mandated protocolized sepsis care and in-hospital mortality among adults with sepsis. JAMA 322(3):240–250PubMedPubMedCentralCrossRef

39.

Morton B, Stolbrink M, Kagima W et al (2018) The early recognition and management of sepsis in Sub-Saharan African adults: a systematic review and meta-analysis. Int J Environ Res Public Health 15(9):2017PubMedCentralCrossRef

40.

Fernando SM, Tran A, Taljaard M et al (2018) Prognostic accuracy of the quick sequential organ failure assessment for mortality in patients with suspected infection: a systematic review and meta-analysis. Ann Intern Med 168(4):266–275PubMedCrossRef

41.

Herwanto V, Shetty A, Nalos M et al (2019) Accuracy of quick sequential organ failure assessment score to predict sepsis mortality in 121 studies including 1,716,017 individuals: a systematic review and meta-analysis. Crit Care Explor. 1(9):e0043PubMedPubMedCentralCrossRef

42.

Serafim R, Gomes JA, Salluh J et al (2018) A comparison of the Quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis. Chest 153(3):646–655PubMedCrossRef

43.

Cinel I, Kasapoglu US, Gul F et al (2020) The initial resuscitation of septic shock. J Crit Care 57:108–117PubMedCrossRef

44.

Liu VX, Lu Y, Carey KA et al (2020) Comparison of early warning scoring systems for hospitalized patients with and without infection at risk for in-hospital mortality and transfer to the intensive care unit. JAMA Netw Open 3(5):e205191PubMedPubMedCentralCrossRef

45.

Borthwick HA, Brunt LK, Mitchem KL et al (2012) Does lactate measurement performed on admission predict clinical outcome on the intensive care unit? A concise systematic review. Ann Clin Biochem 49(Pt 4):391–394PubMedCrossRef

46.

Liu G, An Y, Yi X et al (2017) Early lactate levels for prediction of mortality in patients with sepsis or septic shock: a meta-analysis. Int J Exp Med 10:37–47

47.

Levy MM, Evans LE, Rhodes A (2018) The surviving sepsis campaign bundle: 2018 update. Crit Care Med 46(6):997–1000PubMedCrossRef

48.

Levy MM, Evans LE, Rhodes A (2018) The surviving sepsis campaign bundle: 2018 update. Intensive Care Med 44(6):925–928PubMedCrossRef

49.

Shankar-Hari M, Phillips GS, Levy ML et al (2016) Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):775–787PubMedPubMedCentralCrossRef

50.

Contenti J, Corraze H, Lemoel F et al (2015) Effectiveness of arterial, venous, and capillary blood lactate as a sepsis triage tool in ED patients. Am J Emerg Med 33(2):167–172PubMedCrossRef

51.

Karon BS, Tolan NV, Wockenfus AM et al (2017) Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients. Clin Biochem 50(16–17):956–958PubMedCrossRef

52.

Ljungstrom L, Pernestig AK, Jacobsson G et al (2017) Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One 12(7):e0181704PubMedPubMedCentralCrossRef

53.

Morris E, McCartney D, Lasserson D et al (2017) Point-of-care lactate testing for sepsis at presentation to health care: a systematic review of patient outcomes. Br J Gen Pract 67(665):e859–e870PubMedPubMedCentralCrossRef

54.

Abdu M, Wilson A, Mhango C et al (2018) Resource availability for the management of maternal sepsis in Malawi, other low-income countries, and lower-middle-income countries. Int J Gynaecol Obstet 140(2):175–183PubMedCrossRef

55.

Baelani I, Jochberger S, Laimer T et al (2011) Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: a self-reported, continent-wide survey of anaesthesia providers. Crit Care 15(1):R10PubMedPubMedCentralCrossRef

56.

Baelani I, Jochberger S, Laimer T et al (2012) Identifying resource needs for sepsis care and guideline implementation in the Democratic Republic of the Congo: a cluster survey of 66 hospitals in four eastern provinces. Middle East J Anaesthesiol 21(4):559–575PubMed

57.

Bataar O, Lundeg G, Tsenddorj G et al (2010) Nationwide survey on resource availability for implementing current sepsis guidelines in Mongolia. Bull World Health Organ 88(11):839–846PubMedPubMedCentralCrossRef

58.

Hernandez G, Ospina-Tascon GA, Damiani LP et al (2019) Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA 321(7):654–664PubMedPubMedCentralCrossRef

59.

Machado FR, Cavalcanti AB, Bozza FA et al (2017) The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study. Lancet Infect Dis 17(11):1180–1189PubMedCrossRef

60.

Shrestha GS, Kwizera A, Lundeg G et al (2017) International Surviving Sepsis Campaign guidelines 2016: the perspective from low-income and middle-income countries. Lancet Infect Dis 17(9):893–895PubMedCrossRef

61.

Taniguchi LU, Azevedo LCP, Bozza FA et al (2019) Availability of resources to treat sepsis in Brazil: a random sample of Brazilian institutions. Rev Bras Ter Intensiva 31(2):193–201PubMedPubMedCentralCrossRef

62.

Levy MM, Dellinger RP, Townsend SR et al (2010) The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 36(2):222–231PubMedPubMedCentralCrossRef

63.

Kuttab HI, Lykins JD, Hughes MD et al (2019) Evaluation and predictors of fluid resuscitation in patients with severe sepsis and septic shock. Crit Care Med 47(11):1582–1590PubMedPubMedCentralCrossRef

64.

Investigators P, Yealy DM, Kellum JA et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370(18):1683–1693CrossRef

65.

Peake SL, Delaney A, Bellomo R et al (2015) Goal-directed resuscitation in septic shock. N Engl J Med 372(2):190–191PubMed

66.

Mouncey PR, Osborn TM, Power GS et al (2015) Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372(14):1301–1311PubMedCrossRef

67.

Rowan KM, Angus DC, Bailey M et al (2017) Early, goal-directed therapy for septic shock—a patient-level meta-analysis. N Engl J Med 376(23):2223–2234PubMedCrossRef

68.

Ehrman RR, Gallien JZ, Smith RK et al (2019) Resuscitation guided by volume responsiveness does not reduce mortality in sepsis: a meta-analysis. Crit Care Explor. 1(5):e0015PubMedPubMedCentralCrossRef

69.

Andrews B, Semler MW, Muchemwa L et al (2017) Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. JAMA 318(13):1233–1240PubMedPubMedCentralCrossRef

70.

Aya HD, Rhodes A, Chis Ster I et al (2017) Hemodynamic effect of different doses of fluids for a fluid challenge: a quasi-randomized controlled study. Crit Care Med 45(2):e161–e168PubMedCrossRef

71.

Cherpanath TG, Hirsch A, Geerts BF et al (2016) Predicting fluid responsiveness by passive leg raising: a systematic review and meta-analysis of 23 clinical trials. Crit Care Med 44(5):981–991PubMedCrossRef

72.

Misango D, Pattnaik R, Baker T et al (2017) Haemodynamic assessment and support in sepsis and septic shock in resource-limited settings. Trans R Soc Trop Med Hyg 111(11):483–489PubMedCrossRef

73.

Levy B (2006) Lactate and shock state: the metabolic view. Curr Opin Crit Care 12(4):315–321PubMedCrossRef

74.

Gu WJ, Zhang Z, Bakker J (2015) Early lactate clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials. Intensive Care Med 41(10):1862–1863PubMedCrossRef

75.

Simpson SQ, Gaines M, Hussein Y et al (2016) Early goal-directed therapy for severe sepsis and septic shock: a living systematic review. J Crit Care 36:43–48PubMedCrossRef

76.

Cecconi M, Hernandez G, Dunser M et al (2019) Fluid administration for acute circulatory dysfunction using basic monitoring: narrative review and expert panel recommendations from an ESICM task force. Intensive Care Med 45(1):21–32PubMedCrossRef

77.

Lara B, Enberg L, Ortega M et al (2017) Capillary refill time during fluid resuscitation in patients with sepsis-related hyperlactatemia at the emergency department is related to mortality. PLoS One 12(11):e0188548PubMedPubMedCentralCrossRef

78.

Shrestha GS, Dunser M, Mer M (2017) The forgotten value of the clinical examination to individualize and guide fluid resuscitation in patients with sepsis. Crit Care 21(1):306PubMedPubMedCentralCrossRef

79.

LeDoux D, Astiz ME, Carpati CM et al (2000) Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28(8):2729–2732PubMedCrossRef

80.

Asfar P, Meziani F, Hamel JF et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med 370(17):1583–1593PubMedCrossRef

81.

Hylands M, Moller MH, Asfar P et al (2017) A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension. Can J Anaesth 64(7):703–715PubMedCrossRef

82.

Lamontagne F, Meade MO, Hebert PC et al (2016) Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med 42(4):542–550PubMedCrossRef

83.

Lamontagne F, Richards-Belle A, Thomas K et al (2020) Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA 323(10):938–949PubMedPubMedCentralCrossRef

84.

Mohr NM, Wessman BT, Bassin B et al (2020) Boarding of critically ill patients in the emergency department. Crit Care Med 48(8):1180–1187PubMedPubMedCentralCrossRef

85.

Cardoso LT, Grion CM, Matsuo T et al (2011) Impact of delayed admission to intensive care units on mortality of critically ill patients: a cohort study. Crit Care 15(1):R28PubMedPubMedCentralCrossRef

86.

Groenland CNL, Termorshuizen F, Rietdijk WJR et al (2019) emergency department to icu time is associated with hospital mortality: a registry analysis of 14,788 patients from six University Hospitals in The Netherlands. Crit Care Med 47(11):1564–1571PubMedPubMedCentralCrossRef

87.

Chalfin DB, Trzeciak S, Likourezos A et al (2007) Impact of delayed transfer of critically ill patients from the emergency department to the intensive care unit. Crit Care Med 35(6):1477–1483PubMedCrossRef

88.

Harris S, Singer M, Sanderson C et al (2018) Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strain. Intensive Care Med 44(5):606–615PubMedPubMedCentralCrossRef

89.

Montgomery A, Panagopoulou E, Kehoe I et al (2011) Connecting organisational culture and quality of care in the hospital: is job burnout the missing link? J Health Organ Manag 25(1):108–123PubMedCrossRef

90.

Klein Klouwenberg PM, Cremer OL, van Vught LA et al (2015) Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care 19:319PubMedPubMedCentralCrossRef

91.

Levin PD, Idrees S, Sprung CL et al (2012) Antimicrobial use in the ICU: indications and accuracy—an observational trial. J Hosp Med 7(9):672–678PubMedCrossRef

92.

Minderhoud TC, Spruyt C, Huisman S et al (2017) Microbiological outcomes and antibiotic overuse in Emergency Department patients with suspected sepsis. Neth J Med 75(5):196–203PubMed

93.

Heffner AC, Horton JM, Marchick MR et al (2010) Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis 50(6):814–820PubMedCrossRef

94.

Tidswell R, Parker T, Brealey D, et al (2020) Sepsis–the broken code how accurately is sepsis being diagnosed? J Infect 81(6):e31–e32.

95.

Deuster S, Roten I, Muehlebach S (2010) Implementation of treatment guidelines to support judicious use of antibiotic therapy. J Clin Pharm Ther 35(1):71–78PubMedCrossRef

96.

Ferrer R, Artigas A, Suarez D et al (2009) Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 180(9):861–866PubMedCrossRef

97.

Kalil AC, Johnson DW, Lisco SJ et al (2017) Early goal-directed therapy for sepsis: a novel solution for discordant survival outcomes in clinical trials. Crit Care Med 45(4):607–614PubMedCrossRef

98.

Seymour CW, Gesten F, Prescott HC et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235–2244PubMedPubMedCentralCrossRef

99.

Klompas M, Calandra T, Singer M (2018) Antibiotics for sepsis-finding the equilibrium. JAMA 320(14):1433–1434PubMedCrossRef

100.

Prescott HC, Iwashyna TJ (2019) Improving sepsis treatment by embracing diagnostic uncertainty. Ann Am Thorac Soc 16(4):426–429PubMedPubMedCentralCrossRef

101.

Baggs J, Jernigan JA, Halpin AL et al (2018) Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure. Clin Infect Dis 66(7):1004–1012PubMedCrossRef

102.

Branch-Elliman W, O’Brien W, Strymish J et al (2019) Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events. JAMA Surg 154(7):590–598PubMedPubMedCentralCrossRef

103.

Hranjec T, Rosenberger LH, Swenson B et al (2012) Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis 12(10):774–780PubMedPubMedCentralCrossRef

104.

Ong DSY, Frencken JF, Klein Klouwenberg PMC et al (2017) Short-course adjunctive gentamicin as empirical therapy in patients with severe sepsis and septic shock: a prospective observational cohort study. Clin Infect Dis 64(12):1731–1736PubMedCrossRef

105.

Tamma PD, Avdic E, Li DX et al (2017) Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 177(9):1308–1315PubMedPubMedCentralCrossRef

106.

Teshome BF, Vouri SM, Hampton N et al (2019) Duration of exposure to antipseudomonal beta-lactam antibiotics in the critically ill and development of new resistance. Pharmacotherapy 39(3):261–270PubMedPubMedCentralCrossRef

107.

Contou D, Roux D, Jochmans S et al (2016) Septic shock with no diagnosis at 24 hours: a pragmatic multicenter prospective cohort study. Crit Care 20(1):360PubMedPubMedCentralCrossRef

108.

Rhee C, Kadri SS, Danner RL et al (2016) Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes. Crit Care 20:89PubMedPubMedCentralCrossRef

109.

Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34(6):1589–1596PubMedCrossRef

110.

Liu VX, Fielding-Singh V, Greene JD et al (2017) The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med 196(7):856–863PubMedPubMedCentralCrossRef

111.

Peltan ID, Brown SM, Bledsoe JR et al (2019) ED door-to-antibiotic time and long-term mortality in sepsis. Chest 155(5):938–946PubMedPubMedCentralCrossRef

112.

Abe T, Kushimoto S, Tokuda Y et al (2019) Implementation of earlier antibiotic administration in patients with severe sepsis and septic shock in Japan: a descriptive analysis of a prospective observational study. Crit Care 23(1):360PubMedPubMedCentralCrossRef

113.

Gaieski DF, Mikkelsen ME, Band RA et al (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38(4):1045–1053PubMedCrossRef

114.

Ko BS, Choi SH, Kang GH et al (2020) Time to antibiotics and the outcome of patients with septic shock: a propensity score analysis. Am J Med 133(4):485-91e4PubMedCrossRef

115.

Puskarich MA, Trzeciak S, Shapiro NI et al (2011) Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med 39(9):2066–2071PubMedPubMedCentralCrossRef

116.

Rothrock SG, Cassidy DD, Barneck M, et al (2020) Outcome of immediate versus early antibiotics in severe sepsis and septic shock: a systematic review and meta-analysis. Ann Emerg Med 76(4):427–441

117.

Ryoo SM, Kim WY, Sohn CH et al (2015) Prognostic value of timing of antibiotic administration in patients with septic shock treated with early quantitative resuscitation. Am J Med Sci 349(4):328–333PubMedCrossRef

118.

Weinberger J, Rhee C, Klompas M (2020) A critical analysis of the literature on time-to-antibiotics in suspected sepsis. J Infect Dis 222(Supplement_2):S110–S118PubMedCrossRef

119.

Alam N, Oskam E, Stassen PM et al (2018) Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med 6(1):40–50PubMedCrossRef

120.

Bloos F, Ruddel H, Thomas-Ruddel D et al (2017) Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med 43(11):1602–1612PubMedCrossRef

121.

Chalya PL, Mabula JB, Koy M et al (2012) Typhoid intestinal perforations at a University teaching hospital in Northwestern Tanzania: a surgical experience of 104 cases in a resource-limited setting. World J Emerg Surg 7:4PubMedPubMedCentralCrossRef

122.

Phua J, Koh Y, Du B et al (2011) Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ 342:d3245PubMedPubMedCentralCrossRef

123.

Thwaites CL, Lundeg G, Dondorp AM et al (2016) Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings. Intensive Care Med 42(12):2040–2042PubMedPubMedCentralCrossRef

124.

Urayeneza O, Mujyarugamba P, Rukemba Z et al (2018) Increasing evidence-based interventions in patients with acute infections in a resource-limited setting: a before-and-after feasibility trial in Gitwe, Rwanda. Crit Care Med 46(8):1357–1366PubMedCrossRef

125.

Urayeneza O, Mujyarugamba P, Rukemba Z et al (2018) Increasing evidence-based interventions in patients with acute infections in a resource-limited setting: a before-and-after feasibility trial in Gitwe, Rwanda. Intensive Care Med 44(9):1436–1446PubMedCrossRef

126.

Yokota PK, Marra AR, Martino MD et al (2014) Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock—a quality improvement study. PLoS One 9(11):e104475PubMedPubMedCentralCrossRef

127.

Peng F, Chang W, Xie JF et al (2019) Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: a meta-analysis. Int J Infect Dis 85:158–166PubMedCrossRef

128.

Wacker C, Prkno A, Brunkhorst FM et al (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 13(5):426–435PubMedCrossRef

129.

Jensen JU, Hein L, Lundgren B et al (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 39(9):2048–2058PubMedCrossRef

130.

Layios N, Lambermont B, Canivet JL et al (2012) Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 40(8):2304–2309PubMedCrossRef

131.

Najafi A, Khodadadian A, Sanatkar M et al (2015) The comparison of procalcitonin guidance administer antibiotics with empiric antibiotic therapy in critically ill patients admitted in intensive care unit. Acta Med Iran 53(9):562–567PubMed

132.

Metlay JP, Waterer GW, Long AC et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200(7):e45–e67PubMedPubMedCentralCrossRef

133.

Vincent JL, Sakr Y, Singer M, et al (2020) Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323(15):1478–1487

134.

Jernigan JA, Hatfield KM, Wolford H et al (2020) Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012–2017. N Engl J Med 382(14):1309–1319PubMedCrossRef

135.

Jones M, Jernigan JA, Evans ME et al (2019) Vital Signs: trends in Staphylococcus aureus infections in veterans affairs medical centers—United States, 2005–2017. MMWR Morb Mortal Wkly Rep 68(9):220–224PubMedPubMedCentralCrossRef

136.

Aliberti S, Reyes LF, Faverio P et al (2016) Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis 16(12):1364–1376PubMedCrossRef

137.

Rhee C, Kadri SS, Dekker JP et al (2020) Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 3(4):e202899PubMedPubMedCentralCrossRef

138.

Callejo-Torre F, Eiros Bouza JM, Olaechea Astigarraga P et al (2016) Risk factors for methicillin-resistant Staphylococcus aureus colonisation or infection in intensive care units and their reliability for predicting MRSA on ICU admission. Infez Med 24(3):201–209PubMed

139.

Epstein L, Mu Y, Belflower R et al (2016) Risk factors for invasive methicillin-resistant Staphylococcus aureus infection after recent discharge from an acute-care hospitalization, 2011–2013. Clin Infect Dis 62(1):45–52PubMedCrossRef

140.

Shorr AF, Myers DE, Huang DB et al (2013) A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis 13:268PubMedPubMedCentralCrossRef

141.

Torre-Cisneros J, Natera C, Mesa F et al (2018) Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case-control study. Eur J Clin Microbiol Infect Dis 37(1):51–56PubMedCrossRef

142.

Wooten DA, Winston LG (2013) Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia. Respir Med 107(8):1266–1270PubMedCrossRef

143.

Gasch O, Camoez M, Dominguez MA et al (2013) Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 68(6):1423–1430PubMedCrossRef

144.

Gasch O, Camoez M, Dominguez MA et al (2013) Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy. Clin Microbiol Infect 19(11):1049–1057PubMedCrossRef

145.

Lodise TP, McKinnon PS, Swiderski L et al (2003) Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 36(11):1418–1423PubMedCrossRef

146.

Paul M, Kariv G, Goldberg E et al (2010) Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 65(12):2658–2665PubMedCrossRef

147.

Schramm GE, Johnson JA, Doherty JA et al (2006) Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med 34(8):2069–2074PubMedCrossRef

148.

Fang CT, Shau WY, Hsueh PR et al (2006) Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome. J Antimicrob Chemother 57(3):511–519PubMedCrossRef

149.

Gomez J, Garcia-Vazquez E, Banos R et al (2007) Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis 26(4):239–245PubMedCrossRef

150.

Griffin AT, Peyrani P, Wiemken TL et al (2013) Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia. Infection 41(2):517–523PubMedCrossRef

151.

Kett DH, Cano E, Quartin AA et al (2011) Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 11(3):181–189PubMedCrossRef

152.

Khatib R, Saeed S, Sharma M et al (2006) Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 25(3):181–185PubMedCrossRef

153.

Kim SH, Park WB, Lee KD et al (2004) Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 54(2):489–497PubMedCrossRef

154.

Yoon YK, Park DW, Sohn JW et al (2016) Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis. BMC Infect Dis 16:331PubMedPubMedCentralCrossRef

155.

Jones BE, Ying J, Stevens V, et al (2020) Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia. JAMA Intern Med 180(4):552–560

156.

Webb BJ, Sorensen J, Jephson A, et al (2019) Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study. Eur Respir J 54(1):1900057

157.

Baby N, Faust AC, Smith T, et al (2017) Nasal methicillin-resistant Staphylococcus aureus (MRSA) PCR testing reduces the duration of MRSA-targeted therapy in patients with suspected MRSA pneumonia. Antimicrob Agents Chemother 61(4):e02432-16

158.

Cowley MC, Ritchie DJ, Hampton N et al (2019) Outcomes associated with de-escalating therapy for methicillin-resistant Staphylococcus aureus in culture-negative nosocomial pneumonia. Chest 155(1):53–59PubMedCrossRef

159.

Paonessa JR, Shah RD, Pickens CI et al (2019) Rapid detection of methicillin-resistant Staphylococcus aureus in BAL: a pilot randomized controlled trial. Chest 155(5):999–1007PubMedPubMedCentralCrossRef

160.

Sjovall F, Perner A, Hylander MM (2017) Empirical mono- versus combination antibiotic therapy in adult intensive care patients with severe sepsis—a systematic review with meta-analysis and trial sequential analysis. J Infect 74(4):331–344PubMedCrossRef

161.

Brunkhorst FM, Oppert M, Marx G et al (2012) Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA 307(22):2390–2399PubMedCrossRef

162.

Alevizakos M, Karanika S, Detsis M et al (2016) Colonisation with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents 48(6):647–654PubMedCrossRef

163.

Rottier WC, Bamberg YR, Dorigo-Zetsma JW et al (2015) Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis. Clin Infect Dis 60(11):1622–1630PubMedCrossRef

164.

Rottier WC, van Werkhoven CH, Bamberg YRP et al (2018) Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant enterobacteria in suspected bacterial infections: a nested case-control study. Clin Microbiol Infect 24(12):1315–1321PubMedCrossRef

165.

Arulkumaran N, Routledge M, Schlebusch S et al (2020) Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Med 46(2):225–235PubMedPubMedCentralCrossRef

166.

Bassetti M, Righi E, Ansaldi F et al (2014) A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40(6):839–845PubMedCrossRef

167.

Kollef M, Micek S, Hampton N et al (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54(12):1739–1746PubMedCrossRef

168.

Magill SS, Edwards JR, Bamberg W et al (2014) Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370(13):1198–1208PubMedPubMedCentralCrossRef

169.

Mean M, Marchetti O, Calandra T (2008) Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 12(1):204PubMedPubMedCentralCrossRef

170.

Pappas PG, Kauffman CA, Andes DR et al (2016) Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 62(4):e1-50PubMedCrossRef

171.

Garey KW, Rege M, Pai MP et al (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43(1):25–31PubMedCrossRef

172.

Marriott DJ, Playford EG, Chen S et al (2009) Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care 13(4):R115PubMedPubMedCentralCrossRef

173.

Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49(9):3640–3645PubMedPubMedCentralCrossRef

174.

Timsit JF, Azoulay E, Schwebel C et al (2016) Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, candida colonization, and multiple organ failure: the EMPIRICUS Randomized Clinical Trial. JAMA 316(15):1555–1564PubMedCrossRef

175.

Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 52(4):e56-93PubMedCrossRef

176.

Taplitz RA, Kennedy EB, Bow EJ et al (2018) Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol 36(14):1443–1453PubMedCrossRef

177.

Clancy CJ, Nguyen MH (2018) Diagnosing invasive candidiasis. J Clin Microbiol 56(5):e01909-17

178.

Kullberg BJ, Arendrup MC (2015) Invasive candidiasis. N Engl J Med 373(15):1445–1456PubMedCrossRef

179.

Sandven P, Qvist H, Skovlund E et al (2002) Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 30(3):541–547PubMedCrossRef

180.

Hachem R, Hanna H, Kontoyiannis D et al (2008) The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 112(11):2493–2499PubMedCrossRef

181.

Horn DL, Neofytos D, Anaissie EJ et al (2009) Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48(12):1695–1703PubMedCrossRef

182.

Andes DR, Safdar N, Baddley JW et al (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54(8):1110–1122PubMedCrossRef

183.

Kett DH, Azoulay E, Echeverria PM et al (2011) Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 39(4):665–670PubMedCrossRef

184.

Cleveland AA, Harrison LH, Farley MM et al (2015) Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008–2013: results from population-based surveillance. PLoS One 10(3):e0120452PubMedPubMedCentralCrossRef

185.

Zhang AY, Shrum S, Williams S et al (2020) The changing epidemiology of candidemia in the united states: injection drug use as an increasingly common risk factor-active surveillance in selected sites, United States, 2014–2017. Clin Infect Dis 71(7):1732–1737PubMedCrossRef

186.

Blumberg HM, Jarvis WR, Soucie JM et al (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33(2):177–186PubMedCrossRef

187.

Fan D, Coughlin LA, Neubauer MM et al (2015) Activation of HIF-1alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat Med 21(7):808–814PubMedPubMedCentralCrossRef

188.

Chow JK, Golan Y, Ruthazer R et al (2008) Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 36(7):1993–1998PubMedCrossRef

189.

Ostrosky-Zeichner L, Pappas PG (2006) Invasive candidiasis in the intensive care unit. Crit Care Med 34(3):857–863PubMedCrossRef

190.

Vergidis P, Clancy CJ, Shields RK et al (2016) Intra-abdominal candidiasis: the importance of early source control and antifungal treatment. PLoS One 11(4):e0153247PubMedPubMedCentralCrossRef

191.

Ballard N, Robley L, Barrett D et al (2006) Patients’ recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care 15(1):86–94 (quiz 5)PubMedCrossRef

192.

Horvath EE, Murray CK, Vaughan GM et al (2007) Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann Surg 245(6):978–985PubMedPubMedCentralCrossRef

193.

Murray CK, Loo FL, Hospenthal DR et al (2008) Incidence of systemic fungal infection and related mortality following severe burns. Burns 34(8):1108–1112PubMedCrossRef

194.

Baughman RP, Rhodes JC, Dohn MN et al (1992) Detection of cryptococcal antigen in bronchoalveolar lavage fluid: a prospective study of diagnostic utility. Am Rev Respir Dis 145(5):1226–1229PubMedCrossRef

195.

Ford N, Shubber Z, Jarvis JN et al (2018) CD4 cell count threshold for cryptococcal antigen screening of HIV-infected individuals: a systematic review and meta-analysis. Clin Infect Dis 66(2):S152–S159PubMedPubMedCentralCrossRef

196.

Hage CA, Ribes JA, Wengenack NL et al (2011) A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 53(5):448–454PubMedCrossRef

197.

Clumeck N, Sonnet J, Taelman H et al (1984) Acquired immunodeficiency syndrome in African patients. N Engl J Med 310(8):492–497PubMedCrossRef

198.

Hajjeh RA, Conn LA, Stephens DS et al (1999) Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis 179(2):449–454PubMedCrossRef

199.

Maziarz EK, Perfect JR (2016) Cryptococcosis. Infect Dis Clin N Am 30(1):179–206CrossRef

200.

McCarthy KM, Morgan J, Wannemuehler KA et al (2006) Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence. AIDS 20(17):2199–2206PubMedCrossRef

201.

Husain S, Wagener MM, Singh N (2001) Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 7(3):375–381PubMedPubMedCentralCrossRef

202.

Pappas PG, Alexander BD, Andes DR et al (2010) Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 50(8):1101–1111PubMedCrossRef

203.

Singh N, Gayowski T, Wagener MM et al (1997) Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transplant 11(1):66–70PubMed

204.

Kontoyiannis DP, Marr KA, Park BJ et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50(8):1091–1100PubMedCrossRef

205.

Nath DS, Kandaswamy R, Gruessner R et al (2005) Fungal infections in transplant recipients receiving alemtuzumab. Transplant Proc 37(2):934–936PubMedCrossRef

206.

Tsiodras S, Samonis G, Boumpas DT et al (2008) Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 83(2):181–194PubMedCrossRef

207.

Nsenga L, Kajjimu J, Olum R et al (2021) Cryptococcosis complicating diabetes mellitus: a scoping review. Ther Adv Infect Dis 8:20499361211014770PubMedPubMedCentral

208.

Wald A, Leisenring W, van Burik JA et al (1997) Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 175(6):1459–1466PubMedCrossRef

209.

Mengoli C, Cruciani M, Barnes RA et al (2009) Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 9(2):89–96PubMedCrossRef

210.

White PL, Bretagne S, Klingspor L et al (2010) Aspergillus PCR: one step closer to standardization. J Clin Microbiol 48(4):1231–1240PubMedPubMedCentralCrossRef

211.

White PL, Wingard JR, Bretagne S et al (2015) Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing. Clin Infect Dis 61(8):1293–1303PubMedPubMedCentralCrossRef

212.

Meersseman W, Lagrou K, Maertens J et al (2007) Invasive aspergillosis in the intensive care unit. Clin Infect Dis 45(2):205–216PubMedCrossRef

213.

Barnes PD, Marr KA (2006) Aspergillosis: spectrum of disease, diagnosis, and treatment. Infect Dis Clin N Am. 20(3):545–561 (vi)CrossRef

214.

Gavalda J, Len O, San Juan R et al (2005) Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis 41(1):52–59PubMedCrossRef

215.

Fukuda T, Boeckh M, Carter RA et al (2003) Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 102(3):827–833PubMedCrossRef

216.

Pagano L, Busca A, Candoni A et al (2017) Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations. Blood Rev 31(2):17–29PubMedCrossRef

217.

Baddley JW (2011) Clinical risk factors for invasive aspergillosis. Med Mycol 49(Suppl 1):S7–S12PubMedCrossRef

218.

Ruiz-Camps I, Aguilar-Company J (2021) Risk of infection associated with targeted therapies for solid organ and hematological malignancies. Ther Adv Infect Dis 8:2049936121989548PubMedPubMedCentral

219.

Cantan B, Luyt CE, Martin-Loeches I (2019) Influenza infections and emergent viral infections in intensive care unit. Semin Respir Crit Care Med 40(4):488–497PubMedPubMedCentralCrossRef

220.

Legoff J, Zucman N, Lemiale V et al (2019) Clinical significance of upper airway virus detection in critically ill hematology patients. Am J Respir Crit Care Med 199(4):518–528PubMedCrossRef

221.

Muscedere J, Ofner M, Kumar A et al (2013) The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection. Chest 144(1):39–47PubMedCrossRef

222.

van Someren GF, Juffermans NP, Bos LDJ et al (2018) Respiratory viruses in invasively ventilated critically ill patients-a prospective multicenter observational study. Crit Care Med 46(1):29–36CrossRef

223.

Aziz S, Arabi YM, Alhazzani W, et al (2020) Managing ICU surge during the COVID-19 crisis: rapid guidelines. Intensive Care Med 46(7):1303–1325

224.

Wiersinga WJ, Rhodes A, Cheng AC et al (2020) Pathophysiology, transmission, diagnosis, and rreatment of Coronavirus Disease 2019 (COVID-19): a review. JAMA 324(8):782–793PubMedCrossRef

225.

Muthuri SG, Venkatesan S, Myles PR et al (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2(5):395–404PubMedPubMedCentralCrossRef

226.

Alhazzani W, Moller MH, Arabi YM et al (2020) Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 46(5):854–887PubMedCrossRefPubMedCentral

227.

Tunkel AR, Glaser CA, Bloch KC et al (2008) The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 47(3):303–327PubMedCrossRef

228.

Uyeki TM, Bernstein HH, Bradley JS et al (2019) Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis 68(6):895–902PubMedPubMedCentralCrossRef

229.

Lin GL, McGinley JP, Drysdale SB et al (2018) Epidemiology and immune pathogenesis of viral sepsis. Front Immunol 9:2147PubMedPubMedCentralCrossRef

230.

Goncalves-Pereira J, Povoa P (2011) Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams. Crit Care 15(5):R206PubMedPubMedCentralCrossRef

231.

Mohd Hafiz AA, Staatz CE, Kirkpatrick CM et al (2012) Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics. Minerva Anestesiol 78(1):94–104PubMed

232.

Roberts JA, Abdul-Aziz MH, Davis JS et al (2016) Continuous versus intermittent beta-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials. Am J Respir Crit Care Med 194(6):681–691PubMedCrossRef

233.

Vardakas KZ, Voulgaris GL, Maliaros A et al (2018) Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Lancet Infect Dis 18(1):108–120PubMedCrossRef

234.

De Waele JJ, Lipman J, Carlier M et al (2015) Subtleties in practical application of prolonged infusion of beta-lactam antibiotics. Int J Antimicrob Agents 45(5):461–463PubMedCrossRef

235.

Roberts JA, Paratz J, Paratz E et al (2007) Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. Int J Antimicrob Agents 30(1):11–18PubMedCrossRef

236.

Lipman J, Brett SJ, De Waele JJ et al (2019) A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent beta-lactam antibiotic infusion in critically ill patients with sepsis: BLING III. Crit Care Resusc 21(1):63–68PubMed

237.

Roberts JA, Abdul-Aziz MH, Lipman J et al (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis 14(6):498–509PubMedPubMedCentralCrossRef

238.

Roberts JA, Paul SK, Akova M et al (2014) DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58(8):1072–1083PubMedCrossRef

239.

Veiga RP, Paiva JA (2018) Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients. Crit Care 22(1):233PubMedPubMedCentralCrossRef

240.

Nelson NR, Morbitzer KA, Jordan JD et al (2019) The impact of capping creatinine clearance on achieving therapeutic vancomycin concentrations in neurocritically ill patients with traumatic brain injury. Neurocrit Care 30(1):126–131PubMedCrossRef

241.

Gregoire N, Marchand S, Ferrandiere M et al (2019) Population pharmacokinetics of daptomycin in critically ill patients with various degrees of renal impairment. J Antimicrob Chemother 74(1):117–125PubMed

242.

Ulldemolins M, Roberts JA, Rello J et al (2011) The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet 50(2):99–110PubMedCrossRef

243.

Choi G, Gomersall CD, Tian Q et al (2009) Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med 37(7):2268–2282PubMedCrossRef

244.

Roberts JA, Joynt G, Lee A, et al (2020) The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational SMARRT Study. Clin Infect Dis 72(8):1369–1378

245.

Bougle A, Dujardin O, Lepere V et al (2019) PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support. Anaesth Crit Care Pain Med 38(5):493–497PubMedCrossRef

246.

Cheng V, Abdul-Aziz MH, Roberts JA et al (2019) Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients. Expert Opin Drug Metab Toxicol 15(2):103–112PubMedCrossRef

247.

Guilhaumou R, Benaboud S, Bennis Y et al (2019) Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Societe Francaise de Pharmacologie et Therapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Societe Francaise d’Anesthesie et Reanimation-SFAR). Crit Care 23(1):104PubMedPubMedCentralCrossRef

248.

Turner RB, Kojiro K, Shephard EA et al (2018) Review and validation of bayesian dose-optimizing software and equations for calculation of the vancomycin area under the curve in critically ill patients. Pharmacotherapy 38(12):1174–1183PubMedCrossRef

249.

Rybak M, Lomaestro B, Rotschafer JC et al (2009) Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 66(1):82–98CrossRefPubMed

250.

McKinnon PS, Paladino JA, Schentag JJ (2008) Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents 31(4):345–351PubMedCrossRef

251.

Rayner CR, Forrest A, Meagher AK et al (2003) Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme. Clin Pharmacokinet 42(15):1411–1423PubMedCrossRef

252.

Rubino CM, Bhavnani SM, Forrest A et al (2012) Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia. Antimicrob Agents Chemother 56(1):130–136PubMedPubMedCentralCrossRef

253.

Wong G, Taccone F, Villois P et al (2020) beta-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill. J Antimicrob Chemother 75(2):429–433PubMed

254.

Fleuren LM, Roggeveen LF, Guo T et al (2019) Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study. Crit Care 23(1):185PubMedPubMedCentralCrossRef

255.

Ehmann L, Zoller M, Minichmayr IK et al (2019) Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis. Int J Antimicrob Agents 54(3):309–317PubMedCrossRef

256.

Wong G, Briscoe S, McWhinney B et al (2018) Therapeutic drug monitoring of beta-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures. J Antimicrob Chemother 73(11):3087–3094PubMedCrossRef

257.

Williams P, Beall G, Cotta MO et al (2020) Antimicrobial dosing in critical care: a pragmatic adult dosing nomogram. Int J Antimicrob Agents 55(2):105837PubMedCrossRef

258.

Williams P, Cotta MO, Roberts JA (2019) Pharmacokinetics/Pharmacodynamics of beta-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care Unit. Semin Respir Crit Care Med 40(4):476–487PubMedCrossRef

259.

Nation RL, Garonzik SM, Thamlikitkul V et al (2017) Dosing guidance for intravenous colistin in critically-ill patients. Clin Infect Dis 64(5):565–571PubMed

260.

Roberts JA, Taccone FS, Udy AA et al (2011) Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother 55(6):2704–2709PubMedPubMedCentralCrossRef

261.

Sinnollareddy M, Peake SL, Roberts MS et al (2012) Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review. Int J Antimicrob Agents 39(1):1–10PubMedCrossRef

262.

Jimenez MF, Marshall JC, International Sepsis F (2001) Source control in the management of sepsis. Intensive Care Med 27(Suppl 1):S49-62PubMedCrossRef

263.

Kim H, Chung SP, Choi SH et al (2019) Impact of timing to source control in patients with septic shock: a prospective multi-center observational study. J Crit Care 53:176–182PubMedCrossRef

264.

Martinez ML, Ferrer R, Torrents E et al (2017) Impact of Source Control in Patients With Severe Sepsis and Septic Shock. Crit Care Med 45(1):11–19PubMedCrossRef

265.

Azuhata T, Kinoshita K, Kawano D et al (2014) Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care 18(3):R87PubMedPubMedCentralCrossRef

266.

Bloos F, Thomas-Ruddel D, Ruddel H et al (2014) Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care 18(2):R42PubMedPubMedCentralCrossRef

267.

Buck DL, Vester-Andersen M, Moller MH (2013) Surgical delay is a critical determinant of survival in perforated peptic ulcer. Br J Surg 100(8):1045–1049PubMedCrossRef

268.

Chao WN, Tsai CF, Chang HR et al (2013) Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. Am J Surg 206(1):32–39PubMedCrossRef

269.

Karvellas CJ, Abraldes JG, Zepeda-Gomez S et al (2016) The impact of delayed biliary decompression and anti-microbial therapy in 260 patients with cholangitis-associated septic shock. Aliment Pharmacol Ther 44(7):755–766PubMedCrossRef

270.

Moss RL, Musemeche CA, Kosloske AM (1996) Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival. J Pediatr Surg 31(8):1142–1146PubMedCrossRef

271.

Wong CH, Chang HC, Pasupathy S et al (2003) Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85(8):1454–1460PubMedCrossRef

272.

Solomkin JS, Mazuski JE, Bradley JS et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50(2):133–164PubMedCrossRef

273.

Mermel LA, Allon M, Bouza E et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45CrossRefPubMed

274.

Rijnders BJ, Peetermans WE, Verwaest C et al (2004) Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Med 30(6):1073–1080PubMedCrossRef

275.

Garnacho-Montero J, Aldabo-Pallas T, Palomar-Martinez M et al (2008) Risk factors and prognosis of catheter-related bloodstream infection in critically ill patients: a multicenter study. Intensive Care Med 34(12):2185–2193PubMedCrossRef

276.

Lorente L, Martin MM, Vidal P et al (2014) Should central venous catheter be systematically removed in patients with suspected catheter related infection? Crit Care 18(5):564PubMedPubMedCentralCrossRef

277.

Tabah A, Bassetti M, Kollef MH et al (2020) Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med 46(2):245–265PubMedCrossRef

278.

Leone M, Bechis C, Baumstarck K et al (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40(10):1399–1408PubMedCrossRef

279.

Tabah A, Cotta MO, Garnacho-Montero J et al (2016) A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis 62(8):1009–1017PubMedCrossRef

280.

De Bus L, Depuydt P, Steen J, et al (2020) Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study. Intensive Care Med 46(7):1404–1417

281.

Fernandez-Lazaro CI, Brown KA, Langford BJ et al (2019) Late-career physicians prescribe longer courses of antibiotics. Clin Infect Dis 69(9):1467–1475PubMedCrossRef

282.

Hanretty AM, Gallagher JC (2018) Shortened courses of antibiotics for bacterial infections: a systematic review of randomized controlled trials. Pharmacotherapy 38(6):674–687PubMedCrossRef

283.

Royer S, DeMerle KM, Dickson RP et al (2018) shorter versus longer courses of antibiotics for infection in hospitalized patients: a systematic review and meta-analysis. J Hosp Med 13(5):336–342PubMedCrossRef

284.

Spellberg B (2016) The new antibiotic mantra-"Shorter Is Better". JAMA Intern Med 176(9):1254–1255PubMedPubMedCentralCrossRef

285.

Wald-Dickler N, Spellberg B (2019) Short-course antibiotic therapy-replacing constantine units with “Shorter Is Better.” Clin Infect Dis 69(9):1476–1479PubMedPubMedCentralCrossRef

286.

Chastre J, Wolff M, Fagon JY et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290(19):2588–2598PubMedCrossRef

287.

Choudhury G, Mandal P, Singanayagam A et al (2011) Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis. Clin Microbiol Infect 17(12):1852–1858PubMedCrossRef

288.

Kalil AC, Metersky ML, Klompas M et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society. Clin Infect Dis 63(5):e61–e111PubMedPubMedCentralCrossRef

289.

Vaughn VM, Flanders SA, Snyder A et al (2019) Excess antibiotic treatment duration and adverse events in patients hospitalized with pneumonia: a multihospital cohort study. Ann Intern Med 171(3):153–163PubMedCrossRef

290.

Eliakim-Raz N, Yahav D, Paul M et al (2013) Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection—7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 68(10):2183–2191PubMedCrossRef

291.

Runyon BA, McHutchison JG, Antillon MR et al (1991) Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 100(6):1737–1742PubMedCrossRef

292.

Yahav D, Franceschini E, Koppel F et al (2019) Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled Trial. Clin Infect Dis 69(7):1091–1098PubMedCrossRef

293.

Sawyer RG, Claridge JA, Nathens AB et al (2015) Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 372(21):1996–2005PubMedPubMedCentralCrossRef

294.

Corona A, Bertolini G, Ricotta AM et al (2003) Variability of treatment duration for bacteraemia in the critically ill: a multinational survey. J Antimicrob Chemother 52(5):849–852PubMedCrossRef

295.

Burnham JP, Olsen MA, Stwalley D et al (2018) Infectious diseases consultation reduces 30-day and 1-year all-cause mortality for multidrug-resistant organism infections. Open Forum Infect Dis 5(3):ofy06CrossRef

296.

Macheda G, Dyar OJ, Luc A et al (2018) Are infection specialists recommending short antibiotic treatment durations? An ESCMID international cross-sectional survey. J Antimicrob Chemother 73(4):1084–1090PubMedCrossRef

297.

Madaline T, Wadskier Montagne F, Eisenberg R et al (2019) Early infectious disease consultation is associated with lower mortality in patients with severe sepsis or septic shock who complete the 3-hour sepsis treatment bundle. Open Forum Infect Dis 6(10):ofz408PubMedPubMedCentralCrossRef

298.

Schmitt S, McQuillen DP, Nahass R et al (2014) Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs. Clin Infect Dis 58(1):22–28PubMedCrossRef

299.

Turner RB, Valcarlos E, Won R et al (2016) Impact of infectious diseases consultation on clinical outcomes of patients with staphylococcus aureus bacteremia in a community health system. Antimicrob Agents Chemother 60(10):5682–5687PubMedPubMedCentralCrossRef

300.

Viale P, Tedeschi S, Scudeller L et al (2017) Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department. Clin Infect Dis 65(8):1253–1259PubMedCrossRef

301.

Pugh R, Grant C, Cooke RP et al (2015) Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev 8:CD007577

302.

Havey TC, Fowler RA, Daneman N (2011) Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis. Crit Care 15(6):R267PubMedPubMedCentralCrossRef

303.

Dimopoulos G, Matthaiou DK, Karageorgopoulos DE et al (2008) Short- versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis. Drugs 68(13):1841–1854PubMedCrossRef

304.

Tansarli GS, Andreatos N, Pliakos EE, et al (2019) a systematic review and meta-analysis of antibiotic treatment duration for bacteremia due to enterobacteriaceae. Antimicrob Agents Chemother 63(5):e02495-18

305.

Montravers P, Tubach F, Lescot T et al (2018) Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med 44(3):300–310PubMedCrossRef

306.

Mazuski JE, Sawyer RG, Nathens AB et al (2002) The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt) 3(3):175–233CrossRef

307.

van Engelen TSR, Wiersinga WJ, Scicluna BP et al (2018) Biomarkers in Sepsis. Crit Care Clin 34(1):139–152PubMedCrossRef

308.

Annane D, Maxime V, Faller JP, et al (2013) Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial. BMJ Open 3(2):e002186

309.

Bloos F, Trips E, Nierhaus A et al (2016) Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial. JAMA Intern Med 176(9):1266–1276PubMedCrossRef

310.

Bouadma L, Luyt CE, Tubach F et al (2010) Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375(9713):463–474PubMedCrossRef

311.

de Jong E, van Oers JA, Beishuizen A et al (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 16(7):819–827PubMedCrossRef

312.

Deliberato RO, Marra AR, Sanches PR et al (2013) Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis 76(3):266–271PubMedCrossRef

313.

Hochreiter M, Kohler T, Schweiger AM et al (2009) Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 13(3):R83PubMedPubMedCentralCrossRef

314.

Liu BH, Li HF, Lei Y et al (2013) Clinical significance of dynamic monitoring of procalcitonin in guiding the use of antibiotics in patients with sepsis in ICU. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 25(11):690–693PubMed

315.

Nobre V, Harbarth S, Graf JD et al (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 177(5):498–505PubMedCrossRef

316.

Oliveira CF, Botoni FA, Oliveira CR et al (2013) Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med 41(10):2336–2343PubMedCrossRef

317.

Qu R, Ji Y, Ling Y et al (2012) Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial. Saudi Med J 33(4):382–387PubMed

318.

Schroeder S, Hochreiter M, Koehler T et al (2009) Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 394(2):221–226PubMedCrossRef

319.

Shehabi Y, Sterba M, Garrett PM et al (2014) Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med 190(10):1102–1110PubMedCrossRef

320.

Stolz D, Smyrnios N, Eggimann P et al (2009) Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J 34(6):1364–1375PubMedCrossRef

321.

Xu XL, Yan FD, Yu JQ et al (2017) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment of sepsis patients. Zhonghua Yi Xue Za Zhi 97(5):343–346PubMed

322.

Arulkumaran N, Khpal M, Tam K et al (2020) Effect of antibiotic discontinuation strategies on mortality and infectious complications in critically ill septic patients: a meta-analysis and trial sequential analysis. Crit Care Med 48(5):757–764PubMedCrossRef

323.

Collins CD, Brockhaus K, Sim T et al (2019) Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis. Am J Health Syst Pharm 76(16):1219–1225PubMedCrossRef

324.

Lewis SR, Pritchard MW, Evans DJ et al (2018) Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev 8:CD000567PubMed

325.

Awad S, Allison SP, Lobo DN (2008) The history of 0.9% saline. Clin Nutr 27(2):179–188PubMedCrossRef

326.

Chowdhury AH, Cox EF, Francis ST et al (2012) A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 256(1):18–24PubMedCrossRef

327.

Kellum JA (2002) Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med 30(2):300–305PubMedCrossRef

328.

Kellum JA, Song M, Almasri E (2006) Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest 130(4):962–967PubMedCrossRef

329.

Waters JH, Gottlieb A, Schoenwald P et al (2001) Normal saline versus lactated Ringer’s solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 93(4):817–822PubMedCrossRef

330.

Williams EL, Hildebrand KL, McCormick SA et al (1999) The effect of intravenous lactated Ringer’s solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 88(5):999–1003PubMed

331.

Rochwerg B, Alhazzani W, Sindi A et al (2014) Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161(5):347–355PubMedCrossRef

332.

Young P, Bailey M, Beasley R et al (2015) Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT Randomized Clinical Trial. JAMA 314(16):1701–1710PubMedCrossRef

333.

Semler MW, Wanderer JP, Ehrenfeld JM et al (2017) Balanced crystalloids versus saline in the intensive care unit. The SALT Randomized Trial. Am J Respir Crit Care Med 195(10):1362–1372PubMedPubMedCentralCrossRef

334.

Semler MW, Self WH, Wanderer JP et al (2018) Balanced crystalloids versus saline in critically ill adults. N Engl J Med 378(9):829–839PubMedPubMedCentralCrossRef

335.

Brown RM, Wang L, Coston TD et al (2019) Balanced crystalloids versus saline in sepsis. A secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med 200(12):1487–1495PubMedPubMedCentralCrossRef

336.

Myburgh J (2018) Patient-Centered Outcomes and Resuscitation Fluids. N Engl J Med 378(9):862–863PubMedCrossRef

337.

Zampieri FG, Azevedo LCP, Correa TD et al (2017) Study protocol for the Balanced Solution versus Saline in Intensive Care Study (BaSICS): a factorial randomised trial. Crit Care Resusc 19(2):175–182PubMed

338.

Institute G (2020) Plasma-Lyte 148® versUs Saline Study (PLUS).: ClinicalTrials.gov. Available from: https://clinicaltrials.gov/ct2/show/NCT02721654

339.

Caironi P, Tognoni G, Gattinoni L (2014) Albumin replacement in severe sepsis or septic shock. N Engl J Med 371(1):84PubMed

340.

Martin GS, Bassett P (2019) Crystalloids vs. colloids for fluid resuscitation in the Intensive Care Unit: a systematic review and meta-analysis. J Crit Care 50:144–154PubMedCrossRef

341.

Park CHL, de Almeida JP, de Oliveira GQ et al (2019) Lactated ringer’s versus 4% albumin on lactated ringer’s in early sepsis therapy in cancer patients: a pilot single-center randomized trial. Crit Care Med 47(10):e798–e805PubMedCrossRef

342.

Kakaei FHS, Asheghvatan A, Zarrintan S, Asvadi T, Beheshtirouy S, Mohajer A (2017) Albumin as a resuscitative fluid in patients with severe sepsis: a randomized clinical trial. Adv Biosci Clin Med 5(4):9–16CrossRef

343.

Haase N, Perner A, Hennings LI et al (2013) Hydroxyethyl starch 130/0.38–0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 346:f839PubMedPubMedCentralCrossRef

344.

Annane D, Siami S, Jaber S et al (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310(17):1809–1817PubMedCrossRef

345.

Rochwerg B, Alhazzani W, Gibson A et al (2015) Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Med 41(9):1561–1571PubMedCrossRef

346.

Moeller C, Fleischmann C, Thomas-Rueddel D et al (2016) How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care 35:75–83PubMedCrossRef

347.

Avni T, Lador A, Lev S et al (2015) Vasopressors for the treatment of septic shock: systematic review and meta-analysis. PLoS One 10(8):e0129305PubMedPubMedCentralCrossRef

348.

Regnier B, Safran D, Carlet J et al (1979) Comparative haemodynamic effects of dopamine and dobutamine in septic shock. Intensive Care Med 5(3):115–120PubMedCrossRef

349.

De Backer D, Creteur J, Silva E et al (2003) Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 31(6):1659–1667PubMedCrossRef

350.

Cui J, Wei X, Lv H et al (2019) The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis. Ann Intensive Care 9(1):27PubMedPubMedCentralCrossRef

351.

Myburgh JA, Higgins A, Jovanovska A et al (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34(12):2226–2234PubMedCrossRef

352.

Holmes CL, Patel BM, Russell JA et al (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120(3):989–1002PubMedCrossRef

353.

Landry DW, Levin HR, Gallant EM et al (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95(5):1122–1125PubMedCrossRef

354.

Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509–518PubMedCrossRef

355.

Dunser MW, Mayr AJ, Tur A et al (2003) Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit Care Med 31(5):1394–1398PubMedCrossRef

356.

Russell JA, Walley KR, Singer J et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358(9):877–887PubMedCrossRef

357.

Ukor IF, Walley KR (2019) Vasopressin in Vasodilatory Shock. Crit Care Clin 35(2):247–261PubMedCrossRef

358.

McIntyre WF, Um KJ, Alhazzani W et al (2018) Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA 319(18):1889–1900PubMedPubMedCentralCrossRef

359.

Nagendran M, Russell JA, Walley KR et al (2019) Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med 45(6):844–855PubMedCrossRef

360.

Gamper G, Havel C, Arrich J et al (2016) Vasopressors for hypotensive shock. Cochrane Database Syst Rev 2:CD0037709

361.

Akinaga J, Lima V, Kiguti LR et al (2013) Differential phosphorylation, desensitization, and internalization of alpha1A-adrenoceptors activated by norepinephrine and oxymetazoline. Mol Pharmacol 83(4):870–881PubMedCrossRef

362.

Belletti A, Benedetto U, Biondi-Zoccai G et al (2017) The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials. J Crit Care 37:91–98PubMedCrossRef

363.

Russell JA, Vincent JL, Kjolbye AL et al (2017) Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients. Crit Care 21(1):213PubMedPubMedCentralCrossRef

364.

Laterre PF, Berry SM, Blemings A, et al (2019) Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial. JAMA 322(15):1476–1485

365.

Chawla LS, Busse L, Brasha-Mitchell E et al (2014) Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care 18(5):534PubMedPubMedCentralCrossRef

366.

Khanna A, English SW, Wang XS et al (2017) Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377(5):419–430PubMedCrossRef

367.

Liu ZM, Chen J, Kou Q et al (2018) Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med 44(11):1816–1825PubMedCrossRef

368.

Walley KR (2018) Sepsis-induced myocardial dysfunction. Curr Opin Crit Care 24(4):292–299PubMedCrossRef

369.

Cunha-Goncalves D, Perez-de-Sa V, Larsson A et al (2009) Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine. Anesth Analg 109(5):1576–1583PubMedCrossRef

370.

Dubin A, Lattanzio B, Gatti L (2017) The spectrum of cardiovascular effects of dobutamine—from healthy subjects to septic shock patients. Rev Bras Ter Intensiva 29(4):490–498PubMedPubMedCentralCrossRef

371.

Wilkman E, Kaukonen KM, Pettila V et al (2013) Association between inotrope treatment and 90-day mortality in patients with septic shock. Acta Anaesthesiol Scand 57(4):431–442PubMedCrossRef

372.

Dunser MW, Festic E, Dondorp A et al (2012) Recommendations for sepsis management in resource-limited settings. Intensive Care Med 38(4):557–574PubMedPubMedCentralCrossRef

373.

Gordon AC, Perkins GD, Singer M et al (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375(17):1638–1648PubMedCrossRef

374.

Bhattacharjee S, Soni KD, Maitra S et al (2017) Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: a meta-analysis of randomized controlled trials. J Clin Anesth 39:67–72PubMedCrossRef

375.

Araghi A, Bander JJ, Guzman JA (2006) Arterial blood pressure monitoring in overweight critically ill patients: invasive or noninvasive? Crit Care 10(2):R64PubMedPubMedCentralCrossRef

376.

Bur A, Hirschl MM, Herkner H et al (2000) Accuracy of oscillometric blood pressure measurement according to the relation between cuff size and upper-arm circumference in critically ill patients. Crit Care Med 28(2):371–376PubMedCrossRef

377.

Kaur B, Kaur S, Yaddanapudi LN et al (2019) Comparison between invasive and noninvasive blood pressure measurements in critically ill patients receiving inotropes. Blood Press Monit 24(1):24–29PubMedCrossRef

378.

Lehman LW, Saeed M, Talmor D et al (2013) Methods of blood pressure measurement in the ICU. Crit Care Med 41(1):34–40PubMedPubMedCentralCrossRef

379.

Riley LE, Chen GJ, Latham HE (2017) Comparison of noninvasive blood pressure monitoring with invasive arterial pressure monitoring in medical ICU patients with septic shock. Blood Press Monit 22(4):202–207PubMedCrossRef

380.

Vincent J (2019) Arterial, central venous, and pulmonary artery catheters. In: JE P (ed) Critical care medicine: principles and diagnosis and management in the adult, 5th edn. Elsevier, Philadelphia, pp 40–49

381.

Scheer B, Perel A, Pfeiffer UJ (2002) Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine. Crit Care 6(3):199–204PubMedPubMedCentralCrossRef

382.

Bhattacharjee S, Maitra S, Baidya DK (2018) Comparison between ultrasound guided technique and digital palpation technique for radial artery cannulation in adult patients: an updated meta-analysis of randomized controlled trials. J Clin Anesth 47:54–59PubMedCrossRef

383.

Gu WJ, Wu XD, Wang F et al (2016) Ultrasound guidance facilitates radial artery catheterization: a meta-analysis with trial sequential analysis of randomized controlled trials. Chest 149(1):166–179PubMedCrossRef

384.

O’Horo JC, Maki DG, Krupp AE et al (2014) Arterial catheters as a source of bloodstream infection: a systematic review and meta-analysis. Crit Care Med 42(6):1334–1339PubMedCrossRef

385.

Delaney A, Finnis M, Bellomo R et al (2020) Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a retrospective cohort study. Emerg Med Australas 32(2):210–219PubMedCrossRef

386.

Ricard JD, Salomon L, Boyer A et al (2013) Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med 41(9):2108–2115PubMedCrossRef

387.

Cardenas-Garcia J, Schaub KF, Belchikov YG et al (2015) Safety of peripheral intravenous administration of vasoactive medication. J Hosp Med 10(9):581–585PubMedCrossRef

388.

Tian DH, Smyth C, Keijzers G et al (2020) Safety of peripheral administration of vasopressor medications: a systematic review. Emerg Med Australas 32(2):220–227PubMedCrossRef

389.

Loubani OM, Green RS (2015) A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care 30(3):653e9-17CrossRef

390.

Beck V, Chateau D, Bryson GL et al (2014) Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care 18(3):R97PubMedPubMedCentralCrossRef

391.

Black LP, Puskarich MA, Smotherman C et al (2020) Time to vasopressor initiation and organ failure progression in early septic shock. J Am Coll Emerg Physicians Open 1(3):222–230PubMedPubMedCentralCrossRef

392.

Edaigbini SAAM, Delia IZ, Ibrahim A, Okwunodulo O, Alegbejo-Olarinoye M (2017) Clinical competence with central venous lines by resident doctors in a Nigerian teaching hospital. Sub-Saharan Afr J Med 4:47–51CrossRef

393.

Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–1377PubMedCrossRef

394.

Alphonsus CS, Rodseth RN (2014) The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia 69(7):777–784PubMedCrossRef

395.

Boyd JH, Forbes J, Nakada TA et al (2011) Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 39(2):259–265PubMedCrossRef

396.

Marik PE, Linde-Zwirble WT, Bittner EA et al (2017) Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database. Intensive Care Med 43(5):625–632PubMedCrossRef

397.

Chen C, Kollef MH (2015) Targeted fluid minimization following initial resuscitation in septic shock: a pilot study. Chest 148(6):1462–1469PubMedCrossRef

398.

Corl KA, Prodromou M, Merchant RC et al (2019) The restrictive IV Fluid trial in severe sepsis and septic shock (RIFTS): a randomized pilot study. Crit Care Med 47(7):951–959PubMedPubMedCentralCrossRef

399.

Hjortrup PB, Haase N, Bundgaard H et al (2016) Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med 42(11):1695–1705PubMedCrossRef

400.

Macdonald SPJ, Keijzers G, Taylor DM et al (2018) Restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): a pilot randomised controlled trial. Intensive Care Med 44(12):2070–2078PubMedCrossRef

401.

Semler MW, Janz DR, Casey JD, et al (2019) Conservative fluid management after sepsis resuscitation: a pilot randomized trial. J Intensive Care Med 35(12):1374–1382. https://doi.org/10.1177/0885066618823183

402.

Meyhoff TS, Hjortrup PB, Moller MH et al (2019) Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan. Acta Anaesthesiol Scand 63(9):1262–1271PubMedCrossRef

403.

Self WH, Semler MW, Bellomo R et al (2018) Liberal versus restrictive intravenous fluid therapy for early septic shock: rationale for a randomized trial. Ann Emerg Med 72(4):457–466PubMedPubMedCentralCrossRef

404.

Girardis M, Busani S, Damiani E et al (2016) Effect of Conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the oxygen-ICU randomized clinical trial. JAMA 316(15):1583–1589PubMedCrossRef

405.

Investigators I-R, the A, New Zealand Intensive Care Society Clinical Trials G et al (2020) Conservative Oxygen Therapy during Mechanical Ventilation in the ICU. N Engl J Med 382(11):989–998CrossRef

406.

Panwar R, Hardie M, Bellomo R et al (2016) Conservative versus liberal oxygenation targets for mechanically ventilated patients. A pilot multicenter randomized controlled trial. Am J Respir Crit Care Med 193(1):43–51PubMedCrossRef

407.

Chu DK, Kim LH, Young PJ et al (2018) Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet 391(10131):1693–1705CrossRefPubMed

408.

Young P, Mackle D, Bellomo R et al (2020) Conservative oxygen therapy for mechanically ventilated adults with sepsis: a post hoc analysis of data from the intensive care unit randomized trial comparing two approaches to oxygen therapy (ICU-ROX). Intensive Care Med 46(1):17–26PubMedCrossRef

409.

Barrot L, Asfar P, Mauny F et al (2020) Liberal or conservative oxygen therapy for acute respiratory distress syndrome. N Engl J Med 382(11):999–1008PubMedCrossRef

410.

Mauri T, Turrini C, Eronia N et al (2017) Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med 195(9):1207–1215PubMedCrossRef

411.

Frat JP, Thille AW, Mercat A et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372(23):2185–2196PubMedCrossRef

412.

Ni YN, Luo J, Yu H et al (2018) The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis. Am J Emerg Med 36(2):226–233PubMedCrossRef

413.

Ou X, Hua Y, Liu J et al (2017) Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials. CMAJ 189(7):E260–E267PubMedPubMedCentralCrossRef

414.

Rochwerg B, Granton D, Wang DX et al (2019) High-flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: author’s reply. Intensive Care Med 45(8):1171PubMedCrossRef

415.

Demoule A, Chevret S, Carlucci A et al (2016) Changing use of noninvasive ventilation in critically ill patients: trends over 15 years in francophone countries. Intensive Care Med 42(1):82–92PubMedCrossRef

416.

Demoule A, Girou E, Richard JC et al (2006) Benefits and risks of success or failure of noninvasive ventilation. Intensive Care Med 32(11):1756–1765PubMedCrossRef

417.

Bellani G, Laffey JG, Pham T et al (2017) Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE Study. Am J Respir Crit Care Med 195(1):67–77CrossRefPubMed

418.

Antonelli M, Conti G, Rocco M et al (1998) A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 339(7):429–435PubMedCrossRef

419.

Honrubia T, Garcia Lopez FJ, Franco N et al (2005) Noninvasive vs conventional mechanical ventilation in acute respiratory failure: a multicenter, randomized controlled trial. Chest 128(6):3916–3924PubMedCrossRef

420.

Belenguer-Muncharaz A, Cubedo-Bort M, Blasco-Asensio D et al (2017) Non-invasive ventilation versus invasive mechanical ventilation in patients with hypoxemic acute respiratory failure in an Intensive Care Unit. A randomized controlled study. Minerva Pneumologica 56:1–10

421.

Tonelli R, Fantini R, Tabbi L et al (2020) Early inspiratory effort assessment by esophageal manometry predicts noninvasive ventilation outcome in de novo respiratory failure. A pilot study. Am J Respir Crit Care Med 202(4):558–567PubMedPubMedCentralCrossRef

422.

Bernard GR, Artigas A, Brigham KL et al (1994) The American-European Consensus Conference on ARDS definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149(3 Pt 1):818–824PubMedCrossRef

423.

Force ADT, Ranieri VM, Rubenfeld GD et al (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307(23):2526–2533

424.

Brower RG, Matthay MA, Acute Respiratory Distress Syndrome N et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342(18):1301–1308PubMedCrossRef

425.

Amato MB, Barbas CS, Medeiros DM et al (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338(6):347–354PubMedCrossRef

426.

Brochard L, Roudot-Thoraval F, Roupie E et al (1998) Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 158(6):1831–1838PubMedCrossRef

427.

Brower RG, Shanholtz CB, Fessler HE et al (1999) Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 27(8):1492–1498PubMedCrossRef

428.

Eichacker PQ, Gerstenberger EP, Banks SM et al (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 166(11):1510–1514PubMedCrossRef

429.

Marini JJ, Gattinoni L (2004) Ventilatory management of acute respiratory distress syndrome: a consensus of two. Crit Care Med 32(1):250–255PubMedCrossRef

430.

Tobin MJ (2000) Culmination of an era in research on the acute respiratory distress syndrome. N Engl J Med 342(18):1360–1361PubMedCrossRef

431.

Hager DN, Krishnan JA, Hayden DL et al (2005) Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 172(10):1241–1245PubMedPubMedCentralCrossRef

432.

Checkley W, Brower R, Korpak A et al (2008) Effects of a clinical trial on mechanical ventilation practices in patients with acute lung injury. Am J Respir Crit Care Med 177(11):1215–1222PubMedPubMedCentralCrossRef

433.

Amato MB, Meade MO, Slutsky AS et al (2015) Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 372(8):747–755CrossRefPubMed

434.

Papazian L, Aubron C, Brochard L et al (2019) Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care 9(1):69PubMedPubMedCentralCrossRef

435.

Laffey JG, Bellani G, Pham T et al (2016) Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med 42(12):1865–1876PubMedCrossRef

436.

Villar J, Martin-Rodriguez C, Dominguez-Berrot AM et al (2017) A quantile analysis of plateau and driving pressures: effects on mortality in patients with acute respiratory distress syndrome receiving lung-protective ventilation. Crit Care Med 45(5):843–850PubMedCrossRef

437.

Hodgson CL, Cooper DJ, Arabi Y et al (2019) Maximal recruitment open lung ventilation in acute respiratory distress syndrome (PHARLAP). A phase II, multicenter randomized controlled clinical trial. Am J Respir Crit Care Med 200(11):1363–1372PubMedCrossRef

438.

Cavalcanti AB, Suzumura EA, Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial I et al (2017) Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 318(14):1335–1345PubMedPubMedCentralCrossRef

439.

Brower RG, Lanken PN, MacIntyre N et al (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351(4):327–336PubMedCrossRef

440.

Meade MO, Cook DJ, Guyatt GH et al (2008) Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):637–645PubMedCrossRef

441.

Mercat A, Richard JC, Vielle B et al (2008) Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):646–655PubMedCrossRef

442.

Kacmarek RM, Villar J, Sulemanji D et al (2016) Open lung approach for the acute respiratory distress syndrome: a pilot randomized. controlled trial. Crit Care Med 44(1):32–42PubMedCrossRef

443.

Briel M, Meade M, Mercat A et al (2010) Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 303(9):865–873PubMedCrossRef

444.

Goligher EC, Kavanagh BP, Rubenfeld GD et al (2014) Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials. Am J Respir Crit Care Med 190(1):70–76PubMedCrossRef

445.

Amato MB, Barbas CS, Medeiros DM et al (1995) Beneficial effects of the “open lung approach” with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation. Am J Respir Crit Care Med 152(6 Pt 1):1835–1846PubMedCrossRef

446.

Gattinoni L, Caironi P, Cressoni M et al (2006) Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 354(17):1775–1786PubMedCrossRef

447.

Beitler JR, Sarge T, Banner-Goodspeed VM et al (2019) Effect of titrating positive end-expiratory pressure (PEEP) with an esophageal pressure-guided strategy vs an empirical high PEEP-Fio2 strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 321(9):846–857PubMedPubMedCentralCrossRef

448.

Talmor D, Sarge T, Malhotra A et al (2008) Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 359(20):2095–2104PubMedPubMedCentralCrossRef

449.

Turbil E, Galerneau LM, Terzi N et al (2019) Positive-end expiratory pressure titration and transpulmonary pressure: the EPVENT 2 trial. J Thorac Dis 11(Suppl 15):S2012–S2017PubMedPubMedCentralCrossRef

450.

Serpa Neto A, Cardoso SO, Manetta JA et al (2012) Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA 308(16):1651–1659PubMedCrossRef

451.

Pipeling MR, Fan E (2010) Therapies for refractory hypoxemia in acute respiratory distress syndrome. JAMA 304(22):2521–2527PubMedCrossRef

452.

Cavalcanti AB, Suzumura ÉA, Laranjeira LN et al (2017) Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 318(14):1335–1345PubMedPubMedCentralCrossRef

453.

Fan E, Wilcox ME, Brower RG et al (2008) Recruitment maneuvers for acute lung injury a systematic review. Am J Respir Crit Care Med 178(11):1156–1163PubMedCrossRef

454.

Munshi L, Del Sorbo L, Adhikari NKJ et al (2017) Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 14(Supplement_4):S280-s8CrossRef

455.

Sud S, Friedrich JO, Taccone P et al (2010) Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med 36(4):585–599PubMedCrossRef

456.

Guérin C, Reignier J, Richard JC et al (2013) Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368(23):2159–2168PubMedCrossRef

457.

Jolliet P, Bulpa P, Chevrolet JC (1998) Effects of the prone position on gas exchange and hemodynamics in severe acute respiratory distress syndrome. Crit Care Med 26(12):1977–1985PubMedCrossRef

458.

Lamm WJ, Graham MM, Albert RK (1994) Mechanism by which the prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 150(1):184–193PubMedCrossRef

459.

Stocker R, Neff T, Stein S et al (1997) Prone postioning and low-volume pressure-limited ventilation improve survival in patients with severe ARDS. Chest 111(4):1008–1017PubMedCrossRef

460.

Gattinoni L, Tognoni G, Pesenti A et al (2001) Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 345(8):568–573PubMedCrossRef

461.

Guerin C, Gaillard S, Lemasson S et al (2004) Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 292(19):2379–2387PubMedCrossRef

462.

Klessig HT, Geiger HJ, Murray MJ et al (1992) A National Survey on the practice patterns of anesthesiologist intensivists in the use of muscle-relaxants. Crit Care Med 20(9):1341–1345PubMedCrossRef

463.

Murray MJ, Cowen J, DeBlock H et al (2002) Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 30(1):142–156PubMedCrossRef

464.

Hansenflaschen JH, Brazinsky S, Basile C et al (1991) USE OF sedating drugs and neuromuscular blocking-agents in patients requiring mechanical ventilation for respiratory-failure—a National Survey. JAMA 266(20):2870–2875CrossRef

465.

Forel JM, Roch A, Marin V et al (2006) Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 34(11):2749–2757PubMedCrossRef

466.

Gainnier M, Roch A, Forel JM et al (2004) Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 32(1):113–119PubMedCrossRef

467.

Papazian L, Forel JM, Gacouin A et al (2010) Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363(12):1107–1116PubMedCrossRef

468.

Alhazzani W, Alshahrani M, Jaeschke R et al (2013) Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care 17(2):R43PubMedPubMedCentralCrossRef

469.

Guervilly C, Bisbal M, Forel JM et al (2017) Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome. Intensive Care Med 43(3):408–418PubMedCrossRef

470.

Lyu G, Wang X, Jiang W et al (2014) Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26(5):325–329PubMed

471.

National Heart L, Blood Institute PCTN, Moss M et al (2019) Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med 380(21):1997–2008CrossRef

472.

Alhazzani W, Belley-Cote E, Moller MH, et al (2020) Neuromuscular blockade in patients with ARDS: a rapid practice guideline. Intensive Care Med

473.

Tarazan N, Alshehri M, Sharif S et al (2020) Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials. Intensive Care Med Exp 8(1):61PubMedPubMedCentralCrossRef

474.

Johnson KL, Cheung RB, Johnson SB et al (1999) Therapeutic paralysis of critically ill trauma patients: perceptions of patients and their family members. Am J Crit Care 8(1):490–498PubMedCrossRef

475.

Munshi L, Walkey A, Goligher E et al (2019) Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med 7(2):163–172PubMedCrossRef

476.

Combes A, Hajage D, Capellier G et al (2018) Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 378(21):1965–1975PubMedCrossRef

477.

Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374(9698):1351–1363PubMedCrossRef

478.

Annane D, Renault A, Brun-Buisson C et al (2018) Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med 378(9):809–818PubMedCrossRef

479.

Venkatesh B, Finfer S, Cohen J et al (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 378(9):797–808PubMedCrossRef

480.

Rygård SL, Butler E, Granholm A et al (2018) Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 44(7):1003–1016PubMedCrossRef

481.

Dellinger RP, Bagshaw SM, Antonelli M et al (2018) Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES Randomized Clinical Trial. JAMA 320(14):1455–1463PubMedPubMedCentralCrossRef

482.

Zhou F, Peng Z, Murugan R et al (2013) Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med 41(9):2209–2220PubMedPubMedCentralCrossRef

483.

David S, Bode C, Putensen C et al (2021) Adjuvant therapeutic plasma exchange in septic shock. Intensive Care Med 47(3):352–354PubMedCrossRefPubMedCentral

484.

Hébert PC, Wells G, Blajchman MA et al (1999) a multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340(6):409–417PubMedCrossRef

485.

Holst LB, Haase N, Wetterslev J et al (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371(15):1381–1391PubMedCrossRef

486.

Hirano Y, Miyoshi Y, Kondo Y et al (2019) Liberal versus restrictive red blood cell transfusion strategy in sepsis or septic shock: a systematic review and meta-analysis of randomized trials. Crit Care 23(1):262PubMedPubMedCentralCrossRef

487.

Bergamin FS, Almeida JP, Landoni G et al (2017) Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial. Crit Care Med 45(5):766–773PubMedCrossRef

488.

Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13(3):260–268PubMedPubMedCentralCrossRef

489.

Madsen MB, Hjortrup PB, Hansen MB et al (2017) Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial. Intensive Care Med 43(11):1585–1593PubMedCrossRef

490.

Welte T, Dellinger RP, Ebelt H et al (2018) Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study). Intensive Care Med 44(4):438–448PubMedPubMedCentralCrossRef

491.

Alejandria MM, Lansang MA, Dans LF et al (2013) Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev 9:Cd001090

492.

Busani S, Damiani E, Cavazzuti I et al (2016) Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness. Minerva Anestesiol 82(5):559–572PubMed

493.

Cook DJ, Fuller HD, Guyatt GH et al (1994) Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 330(6):377–381CrossRefPubMed

494.

Krag M, Marker S, Perner A et al (2018) Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. N Engl J Med 379(23):2199–2208CrossRefPubMed

495.

D'Silva KM, Mehta R, Mitchell M, et al (2021) Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. Clin Microbiol Infect

496.

Granholm A, Zeng L, Dionne JC et al (2019) Predictors of gastrointestinal bleeding in adult ICU patients: a systematic review and meta-analysis. Intensive Care Med 45(10):1347–1359PubMedCrossRef

497.

Cook D, Crowther M, Meade M et al (2005) Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 33(7):1565–1571PubMedCrossRef

498.

Alhazzani W, Lim W, Jaeschke RZ et al (2013) Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 41(9):2088–2098PubMedCrossRef

499.

Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e195S-e226SPubMedPubMedCentralCrossRef

500.

Arabi YM, Al-Hameed F, Burns KEA et al (2019) Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. N Engl J Med 380(14):1305–1315PubMedCrossRef

501.

Kellum JA, Angus DC, Johnson JP et al (2002) Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 28(1):29–37PubMedCrossRef

502.

Tonelli M, Manns B, Feller-Kopman D (2002) Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40(5):875–885PubMedCrossRef

503.

Zha J, Li C, Cheng G et al (2019) The efficacy of renal replacement therapy strategies for septic-acute kidney injury: a PRISMA-compliant network meta-analysis. Medicine (Baltimore) 98(16):e15257CrossRef

504.

Zhao Y, Chen Y (2020) Effect of renal replacement therapy modalities on renal recovery and mortality for acute kidney injury: A PRISMA-compliant systematic review and meta-analysis. Semin Dial 33(2):127–132PubMedCrossRef

505.

Zarbock A, Kellum JA, Schmidt C et al (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN Randomized Clinical Trial. JAMA 315(20):2190–2199PubMedCrossRef

506.

Gaudry S, Hajage D, Schortgen F et al (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375(2):122–133PubMedCrossRef

507.

Barbar SD, Clere-Jehl R, Bourredjem A et al (2018) Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 379(15):1431–1442PubMedCrossRef

508.

Investigators S-A, Canadian Critical Care Trials G, Australian et al (2020) Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med 383(3):240–251CrossRef

509.

Badawi O, Waite MD, Fuhrman SA et al (2012) Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med 40(12):3180–3188PubMedCrossRef

510.

Krinsley JS (2008) Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 36(11):3008–3013PubMedCrossRef

511.

Siegelaar SE, Hermanides J, Oudemans-van Straaten HM et al (2010) Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study. Crit Care 14(6):R224PubMedPubMedCentralCrossRef

512.

Diabetes Care in the Hospital (2018) Standards of Medical Care in Diabetes—2018. Diabetes Care 41(Supplement 1):S144–S151

513.

van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345(19):1359–1367PubMedCrossRef

514.

Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358(2):125–139PubMedCrossRef

515.

Preiser JC, Devos P, Ruiz-Santana S et al (2009) A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 35(10):1738–1748PubMedCrossRef

516.

Griesdale DE, de Souza RJ, van Dam RM et al (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180(8):821–827PubMedCrossRef

517.

Song F, Zhong LJ, Han L, et al (2014) Intensive insulin therapy for septic patients: a meta-analysis of randomized controlled trials. Biomed Res Int 2014:698265. https://doi.org/10.1155/2014/698265

518.

The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–1297

519.

Yatabe T, Inoue S, Sakaguchi M et al (2017) The optimal target for acute glycemic control in critically ill patients: a network meta-analysis. Intensive Care Med 43(1):16–28PubMedCrossRef

520.

Kuhn SO, Meissner K, Mayes LM et al (2018) Vitamin C in sepsis. Curr Opin Anaesthesiol 31(1):55–60PubMedPubMedCentralCrossRef

521.

Marik PE, Khangoora V, Rivera R et al (2017) Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 151(6):1229–1238PubMedCrossRef

522.

Putzu A, Daems AM, Lopez-Delgado JC et al (2019) The effect of vitamin c on clinical outcome in critically ill patients: a systematic review with meta-analysis of randomized controlled trials. Crit Care Med 47(6):774–783PubMedCrossRef

523.

Fowler AA 3rd, Truwit JD, Hite RD et al (2019) Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI Randomized Clinical Trial. JAMA 322(13):1261–1270PubMedPubMedCentralCrossRef

524.

Fujii T, Luethi N, Young PJ et al (2020) Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS Randomized Clinical Trial. JAMA 323(5):423–431PubMedPubMedCentralCrossRef

525.

Moskowitz A, Huang DT, Hou PC et al (2020) Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS Randomized Clinical Trial. JAMA 324(7):642–650PubMedPubMedCentralCrossRef

526.

Cooper DJ, Walley KR, Wiggs BR et al (1990) Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med 112(7):492–498PubMedCrossRef

527.

Mathieu D, Neviere R, Billard V et al (1991) Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 19(11):1352–1356PubMedCrossRef

528.

Jaber S, Paugam C, Futier E et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet 392(10141):31–40PubMedCrossRef

529.

Kudsk KA (2002) Current aspects of mucosal immunology and its influence by nutrition. Am J Surg 183(4):390–398PubMedCrossRef

530.

McClave SA, Heyland DK (2009) The physiologic response and associated clinical benefits from provision of early enteral nutrition. Nutr Clin Pract 24(3):305–315PubMedCrossRef

531.

Reignier J, Boisramé-Helms J, Brisard L et al (2018) Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). Lancet 391(10116):133–143PubMedCrossRef

532.

Ibrahim EH, Mehringer L, Prentice D et al (2002) Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr 26(3):174–181PubMedCrossRef

533.

Malhotra A, Mathur AK, Gupta S (2004) Early enteral nutrition after surgical treatment of gut perforations: a prospective randomised study. J Postgrad Med 50(2):102–106PubMed

534.

Pupelis G, Austrums E, Jansone A et al (2000) Randomised trial of safety and efficacy of postoperative enteral feeding in patients with severe pancreatitis: preliminary report. Eur J Surg 166(5):383–387PubMedCrossRef

535.

Singh G, Ram RP, Khanna SK (1998) Early postoperative enteral feeding in patients with nontraumatic intestinal perforation and peritonitis. J Am Coll Surg 187(2):142–146PubMedCrossRef

536.

Ely EW (2017) The ABCDEF Bundle: science and philosophy of how ICU liberation serves patients and families. Crit Care Med 45(2):321–330PubMedPubMedCentralCrossRef

537.

Brinkman-Stoppelenburg A, Rietjens JA, van der Heide A (2014) The effects of advance care planning on end-of-life care: a systematic review. Palliat Med 28(8):1000–1025PubMedCrossRef

538.

White DB, Angus DC, Shields AM et al (2018) A randomized trial of a family-support intervention in intensive care units. N Engl J Med 378(25):2365–2375PubMedCrossRef

539.

Schneiderman LJ, Gilmer T, Teetzel HD (2000) Impact of ethics consultations in the intensive care setting: a randomized, controlled trial. Crit Care Med 28(12):3920–3924PubMedCrossRef

540.

Schneiderman LJ, Gilmer T, Teetzel HD et al (2003) Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial. JAMA 290(9):1166–1172PubMedCrossRef

541.

Chen C, Michaels J, Meeker MA (2019) Family outcomes and perceptions of end-of-life care in the intensive care unit: a mixed-methods review. J Palliat Care 35(3):143–153. https://doi.org/10.1177/0825859719874767

542.

Andereck WS, McGaughey JW, Schneiderman LJ et al (2014) Seeking to reduce nonbeneficial treatment in the ICU: an exploratory trial of proactive ethics intervention. Crit Care Med 42(4):824–830PubMedCrossRef

543.

Carson SS, Cox CE, Wallenstein S et al (2016) Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial. JAMA 316(1):51–62PubMedPubMedCentralCrossRef

544.

Picker D, Dans M, Heard K et al (2017) A randomized trial of palliative care discussions linked to an automated early warning system alert. Crit Care Med 45(2):234–240PubMedCrossRef

545.

Cheung W, Aggarwal G, Fugaccia E et al (2010) Palliative care teams in the intensive care unit: a randomised, controlled, feasibility study. Crit Care Resusc 12(1):28–35PubMed

546.

Curtis JR, Nielsen EL, Treece PD et al (2011) Effect of a quality-improvement intervention on end-of-life care in the intensive care unit: a randomized trial. Am J Respir Crit Care Med 183(3):348–355PubMedCrossRef

547.

Lautrette A, Darmon M, Megarbane B et al (2007) A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med 356(5):469–478PubMedCrossRef

548.

Ma J, Chi S, Buettner B et al (2019) Early palliative care consultation in the medical ICU: a cluster randomized crossover trial. Crit Care Med 47(12):1707–1715PubMedPubMedCentralCrossRef

549.

Clark E, MacCrosain A, Ward NS et al (2020) The key features and role of peer support within group self-management interventions for stroke? A systematic review. Disabil Rehabil 42(3):307–316PubMedCrossRef

550.

Govindan S, Iwashyna TJ, Watson SR et al (2014) Issues of survivorship are rarely addressed during intensive care unit stays. Baseline results from a statewide quality improvement collaborative. Ann Am Thorac Soc 11(4):587–591PubMedPubMedCentralCrossRef

551.

Wobma R, Nijland RH, Ket JC et al (2016) Evidence for peer support in rehabilitation for individuals with acquired brain injury: a systematic review. J Rehabil Med 48(10):837–840PubMedCrossRef

552.

McPeake J, Hirshberg EL, Christie LM et al (2019) Models of peer support to remediate post-intensive care xyndrome: a report developed by the Society of Critical Care Medicine Thrive International Peer Support Collaborative. Crit Care Med 47(1):e21–e27PubMedPubMedCentralCrossRef

553.

Mikkelsen ME, Jackson JC, Hopkins RO et al (2016) Peer support as a novel strategy to mitigate post-intensive care syndrome. AACN Adv Crit Care 27(2):221–229PubMedCrossRef

554.

Halm MA (1990) Effects of support groups on anxiety of family members during critical illness. Heart Lung 19(1):62–71PubMed

555.

Fridlund B, Stener-Bengtsson A, Wannman AL (1993) Social support and social network after acute myocardial infarction; the critically ill male patient’s needs, choice and motives. Intensive Crit Care Nurs 9(2):88–94PubMedCrossRef

556.

McPeake J, Shaw M, Iwashyna TJ et al (2017) Intensive care syndrome: promoting independence and return to employment (InS:PIRE). Early evaluation of a complex intervention. PLoS One 12(11):e0188028PubMedPubMedCentralCrossRef

557.

Sabo KA, Kraay C, Rudy E et al (1989) ICU family support group sessions: family members’ perceived benefits. Appl Nurs Res 2(2):82–89PubMedCrossRef

558.

Parent N, Fortin F (2000) A randomized, controlled trial of vicarious experience through peer support for male first-time cardiac surgery patients: impact on anxiety, self-efficacy expectation, and self-reported activity. Heart Lung 29(6):389–400PubMedCrossRef

559.

Damianakis T, Tough A, Marziali E et al (2016) Therapy online: A web-based video support group for family caregivers of survivors with traumatic brain injury. J Head Trauma Rehabil 31(4):E12-20PubMedCrossRef

560.

Harvey C, Dixon M, Padberg N (1995) Support group for families of trauma patients: a unique approach. Crit Care Nurse 15(4):59–63PubMedCrossRef

561.

Jones C, Macmillan RR, Griffiths RD (1994) Providing psychological support for patients after critical illness. Clin Intensive Care 5(4):176–179PubMed

562.

Peskett M, Gibb P (2009) Developing and setting up a patient and relatives intensive care support group. Nurs Crit Care 14(1):4–10PubMedCrossRef

563.

Sacco TL, Stapleton MF, Ingersoll GL (2009) Support groups facilitated by families of former patients: creating family-inclusive critical care units. Crit Care Nurse 29(3):36–45PubMedCrossRef

564.

Haines KJ, Beesley SJ, Hopkins RO et al (2018) Peer support in critical care: a systematic review. Crit Care Med 46(9):1522–1531PubMedCrossRef

565.

Danesh V (2019) A prospective, 2-arm, single-blind, randomized controlled clinical feasibility trial design is planned. Forty CCI survivors will be randomized (1:1) to either the PS-PICS (peer support) intervention or usual care (control) group. NCT03788096 2019 Available from: https://clinicaltrials.gov/ct2/show/study/NCT03788096

566.

Haines KJHC, Cranwell K, Skinner EH, Holton S, MacLeod-Smith B, Bates S, Iwashyna TJ, French C, Booth S, Carmody J (2019) Development of a peer support model using experience-based co-design to improve critical care recovery. Crit Care Explor. 1(3):e0006PubMedPubMedCentralCrossRef

567.

Matthaeus-Kraemer CT, Thomas-Rueddel DO, Schwarzkopf D et al (2016) Crossing the handover chasm: Clinicians’ perceptions of barriers to the early detection and timely management of severe sepsis and septic shock. J Crit Care 36:85–91PubMedCrossRef

568.

Parent B, LaGrone LN, Albirair MT et al (2018) Effect of standardized handoff curriculum on improved clinician preparedness in the intensive care unit: a stepped-wedge cluster randomized clinical trial. JAMA Surg 153(5):464–470PubMedCrossRefPubMedCentral

569.

Nanchal R, Aebly B, Graves G et al (2017) Controlled trial to improve resident sign-out in a medical intensive care unit. BMJ Qual Saf 26(12):987–992PubMedCrossRef

570.

Hess DR, Tokarczyk A, O’Malley M et al (2010) The value of adding a verbal report to written handoffs on early readmission following prolonged respiratory failure. Chest 138(6):1475–1479PubMedCrossRef

571.

Hoffman RL, Saucier J, Dasani S et al (2017) Development and implementation of a risk identification tool to facilitate critical care transitions for high-risk surgical patients. Int J Qual Health Care 29(3):412–419PubMedPubMedCentralCrossRef

572.

Chaboyer W, Lin F, Foster M et al (2012) Redesigning the ICU nursing discharge process: a quality improvement study. Worldviews Evid Based Nurs 9(1):40–48PubMedCrossRef

573.

Medlock S, Eslami S, Askari M et al (2011) Improved communication in post-ICU care by improving writing of ICU discharge letters: a longitudinal before-after study. BMJ Qual Saf 20(11):967–973PubMedCrossRef

574.

Griffiths J, Hatch RA, Bishop J et al (2013) An exploration of social and economic outcome and associated health-related quality of life after critical illness in general intensive care unit survivors: a 12-month follow-up study. Crit Care 17(3):R100PubMedPubMedCentralCrossRef

575.

Donnelly JP, Lakkur S, Judd SE et al (2018) Association of neighborhood socioeconomic status with risk of infection and sepsis. Clin Infect Dis 66(12):1940–1947PubMedPubMedCentralCrossRef

576.

Koch K, Norgaard M, Schonheyder HC et al (2013) Effect of socioeconomic status on mortality after bacteremia in working-age patients A Danish population-based cohort study. PLoS One 8(7):e70082PubMedPubMedCentralCrossRef

577.

Ho KM, Dobb GJ, Knuiman M et al (2008) The effect of socioeconomic status on outcomes for seriously ill patients: a linked data cohort study. Med J Aust 189(1):26–30PubMedCrossRef

578.

Ogundipe F, Kodadhala V, Ogundipe T et al (2019) Disparities in sepsis mortality by region, urbanization, and race in the USA: a Multiple Cause of Death Analysis. J Racial Ethn Health Dispar 6(3):546–551CrossRef

579.

Goodwin AJ, Nadig NR, McElligott JT et al (2016) Where you live matters: the impact of place of residence on severe sepsis incidence and mortality. Chest 150(4):829–836PubMedPubMedCentralCrossRef

580.

Prescott HC, Angus DC (2018) Enhancing recovery from sepsis: a review. JAMA 319(1):62–75PubMedPubMedCentralCrossRef

581.

Gruther W, Pieber K, Steiner I et al (2017) Can early rehabilitation on the general ward after an intensive care unit stay reduce hospital length of stay in survivors of critical illness?: A randomized controlled trial. Am J Phys Med Rehabil 96(9):607–615PubMedCrossRef

582.

Huang CY, Daniels R, Lembo A et al (2019) Life after sepsis: an international survey of survivors to understand the post-sepsis syndrome. Int J Qual Health Care 31(3):191–198PubMedCrossRef

583.

Azoulay E, Pochard F, Chevret S et al (2002) Impact of a family information leaflet on effectiveness of information provided to family members of intensive care unit patients: a multicenter, prospective, randomized, controlled trial. Am J Respir Crit Care Med 165(4):438–442PubMedCrossRef

584.

Bench S, Day T, Heelas K et al (2015) Evaluating the feasibility and effectiveness of a critical care discharge information pack for patients and their families: a pilot cluster randomised controlled trial. BMJ Open 5(11):e006852PubMedPubMedCentralCrossRef

585.

Demircelik MB, Cakmak M, Nazli Y et al (2016) Effects of multimedia nursing education on disease-related depression and anxiety in patients staying in a coronary intensive care unit. Appl Nurs Res 29:5–8PubMedCrossRef

586.

Fleischer S, Berg A, Behrens J et al (2014) Does an additional structured information program during the intensive care unit stay reduce anxiety in ICU patients?: a multicenter randomized controlled trial. BMC Anesthesiol 14:48PubMedPubMedCentralCrossRef

587.

Gehrke-Beck S, Bänfer M, Schilling N et al (2017) The specific needs of patients following sepsis: a nested qualitative interview study. BJGP Open. 1(1):bjgpopen17X100725PubMedPubMedCentralCrossRef

588.

Schmidt K, Worrack S, Von Korff M et al (2016) Effect of a primary care management intervention on mental health-related quality of life among survivors of sepsis: a randomized clinical trial. JAMA 315(24):2703–2711PubMedCrossRef

589.

Oermann MH, McInerney SM (2007) An evaluation of sepsis Web sites for patient and family education. Plast Surg Nurs 27(4):192–196PubMedCrossRef

590.

Légaré F, Adekpedjou R, Stacey D et al (2018) Interventions for increasing the use of shared decision making by healthcare professionals. Cochrane Database Syst Rev 7(7):Cd006732PubMed

591.

Anderson WG, Arnold RM, Angus DC et al (2009) Passive decision-making preference is associated with anxiety and depression in relatives of patients in the intensive care unit. J Crit Care 24(2):249–254PubMedCrossRef

592.

Bokinskie JC (1992) Family conferences: a method to diminish transfer anxiety. J Neurosci Nurs 24(3):129–133PubMedCrossRef

593.

Choi J, Lingler JH, Donahoe MP et al (2018) Home discharge following critical illness: a qualitative analysis of family caregiver experience. Heart Lung 47(4):401–407PubMedPubMedCentralCrossRef

594.

Moss KO, Douglas SL, Baum E et al (2019) Family surrogate decision-making in chronic critical Illness: a qualitative analysis. Crit Care Nurse 39(3):e18–e26PubMedPubMedCentralCrossRef

595.

Austin CA, Mohottige D, Sudore RL et al (2015) Tools to promote shared decision making in serious illness: a systematic review. JAMA Intern Med 175(7):1213–1221PubMedPubMedCentralCrossRef

596.

Bell CM, Brener SS, Gunraj N et al (2011) Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA 306:840–847PubMedCrossRef

597.

Fabes J, Seligman W, Barrett C et al (2017) Does the implementation of a novel intensive care discharge risk score and nurse-led inpatient review tool improve outcome? A prospective cohort study in two intensive care units in the UK. BMJ Open 7(12):e018322PubMedPubMedCentralCrossRef

598.

Mekonnen AB, McLachlan AJ, Brien JA (2016) Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis. J Clin Pharm Ther 41(2):128–144PubMedCrossRef

599.

Morandi A, Vasilevskis E, Pandharipande PP et al (2013) Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalization. J Am Geriatr Soc 61:1128–1134PubMedPubMedCentralCrossRef

600.

Scales DC, Fischer HD, Li P et al (2016) Unintentional continuation of medications intended for acute illness after hospital discharge: A population-based cohort study. J Gen Intern Med 31:196–202PubMedCrossRef

601.

Stelfox HT, Bastos J, Niven DJ et al (2016) Critical care transition programs and the risk of readmission or death after discharge from ICU. Intensive Care Med 42(3):401–410PubMedCrossRef

602.

Tomichek JE, Stollings JL, Pandharipande PP et al (2016) Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study. Crit Care 20:378PubMedPubMedCentralCrossRef

603.

Ball C, Kirkby M, Williams S (2003) Effect of the critical care outreach team on patient survival to discharge from hospital and readmission to critical care: non-randomised population based study. BMJ 327(7422):1014PubMedPubMedCentralCrossRef

604.

Baxter AD, Cardinal P, Hooper J et al (2008) Medical emergency teams at The Ottawa Hospital: the first two years. Can J Anaesth 55(4):223–231PubMedCrossRef

605.

Choi S, Lee J, Shin Y et al (2016) Effects of a medical emergency team follow-up programme on patients discharged from the medical intensive care unit to the general ward: a single-centre experience. J Eval Clin Pract 22(3):356–362PubMedCrossRef

606.

Elliott D, McKinley S, Alison J et al (2011) Health-related quality of life and physical recovery after a critical illness: a multi-centre randomised controlled trial of a home-based physical rehabilitation program. Crit Care 15:R142PubMedPubMedCentralCrossRef

607.

Garcea G, Thomasset S, McClelland L et al (2004) Impact of a critical care outreach team on critical care readmissions and mortality. Acta Anaesthesiol Scand 48(9):1096–1100PubMedCrossRef

608.

Green A, Edmonds L (2004) Bridging the gap between the intensive care unit and general wards-the ICU Liaison Nurse. Intensive Crit Care Nurs 20(3):133–143PubMedCrossRef

609.

Leary T, Ridley S (2003) Impact of an outreach team on re-admissions to a critical care unit. Anaesthesia 58(4):328–332PubMedCrossRef

610.

Pittard AJ (2003) Out of our reach? Assessing the impact of introducing a critical care outreach service. Anaesthesia 58(9):882–885PubMedCrossRef

611.

Williams TA, Leslie G, Finn J et al (2010) Clinical effectiveness of a critical care nursing outreach service in facilitating discharge from the intensive care unit. Am J Crit Care 19(5):e63-72PubMedCrossRef

612.

Pronovost P, Weast B, Schwarz M et al (2003) Medication reconciliation: a practical tool to reduce the risk of medication errors. J Crit Care 18(4):201–205PubMedCrossRef

613.

Ravn-Nielsen LV, Duckert ML, Lund ML et al (2018) Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. JAMA Intern Med 178(3):375–382PubMedPubMedCentralCrossRef

614.

Taylor SP, Chou SH, Sierra MF et al (2020) Association between Adherence to Recommended Care and Outcomes for Adult Survivors of Sepsis. Ann Am Thorac Soc 17(1):89–97PubMedPubMedCentralCrossRef

615.

Etesse B, Jaber S, Mura T et al (2010) How the relationships between general practitioners and intensivists can be improved: the general practitioners’ point of view. Crit Care 14(3):R112PubMedPubMedCentralCrossRef

616.

Kripalani S, LeFevre F, Phillips CO et al (2007) Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA 297:831–841PubMedCrossRef

617.

Robelia PM, Kashiwagi DT, Jenkins SM et al (2017) Information transfer and the hospital discharge summary: National primary care provider perspectives of challenges and opportunities. J Am Board Fam Med 30(6):758–765PubMedCrossRef

618.

Weissman GE, Harhay MO, Lugo RM et al (2016) Natural language processing to assess documentation of features of critical illness in discharge documents of acute respiratory distress syndrome survivors. Ann Am Thorac Soc 13(9):1538–1545PubMedPubMedCentralCrossRef

619.

Needham DM, Davidson J, Cohen H et al (2012) Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med 40:502–509PubMedCrossRef

620.

Iwashyna TJ, Ely EW, Smith DM et al (2010) Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304:1787–1794PubMedPubMedCentralCrossRef

621.

Konig C, Matt B, Kortgen A et al (2019) What matters most to sepsis survivors: a qualitative analysis to identify specific health-related quality of life domains. Qual Life Res 28(3):637–647PubMedCrossRef

622.

Dietz BW, Jones TK, Small DS et al (2017) The relationship between index hospitalizations, sepsis, and death or transition to hospice care during 30-day hospital readmissions. Med Care 55(4):362–370PubMedCrossRef

623.

Ortego A, Gaieski DF, Fuchs BD et al (2015) Hospital-based acute care use in survivors of septic shock. Crit Care Med 43(4):729–737PubMedPubMedCentralCrossRef

624.

Mayr FB, Talisa VB, Balakumar V et al (2017) Proportion and cost of unplanned 30-day readmissions after sepsis compared with other medical conditions. JAMA 317(5):530–531PubMedCrossRef

625.

Hernandez AF, Greiner MA, Fonarow GC et al (2010) Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 303(17):1716–1722PubMedCrossRef

626.

Field TS, Ogarek J, Garber L et al (2015) Association of early post-discharge follow-up by a primary care physician and 30-day rehospitalization among older adults. J Gen Intern Med 30(5):565–571PubMedCrossRef

627.

Shen E, Koyama SY, Huynh DN et al (2017) Association of a dedicated post-hospital discharge follow-up visit and 30-Day readmission risk in a Medicare Advantage population. JAMA Intern Med 177(1):132–135PubMedCrossRef

628.

Douglas SL, Daly BJ, Kelley CG et al (2007) Chronically critically ill patients: health-related quality of life and resource use after a disease management intervention. Am J Crit Care 16(5):447–457PubMedPubMedCentralCrossRef

629.

Jónasdóttir RJ, Jónsdóttir H, Gudmundsdottir B et al (2018) Psychological recovery after intensive care: Outcomes of a long-term quasi-experimental study of structured nurse-led follow-up. Intensive Crit Care Nurs 44:59–66PubMedCrossRef

630.

Kansagara D, Ramsay RS, Labby D et al (2012) Post-discharge intervention in vulnerable, chronically ill patients. J Hosp Med 7(2):124–130PubMedCrossRef

631.

Deb P, Murtaugh CM, Bowles KH et al (2019) Does early follow-up improve the outcomes of sepsis survivors discharged to home health care? Med Care 57(8):633–640PubMedCrossRef

632.

Annane D, Sharshar T (2015) Cognitive decline after sepsis. Lancet Respir Med 3(1):61–69PubMedCrossRef

633.

Jackson JC, Ely EW, Morey MC et al (2012) Cognitive and physical rehabilitation of intensive care unit survivors: results of the RETURN randomized controlled pilot investigation. Crit Care Med 40(4):1088–1097PubMedPubMedCentralCrossRef

634.

Brummel NE, Girard TD, Ely EW et al (2014) Feasibility and safety of early combined cognitive and physical therapy for critically ill medical and surgical patients: the Activity and Cognitive Therapy in ICU (ACT-ICU) trial. Intensive Care Med 40(3):370–379PubMedCrossRef

635.

Zhao J, Yao L, Li M et al (2019) Effects of early intervention training on cognitive impairment in critical patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 31(3):298–302PubMed

636.

Wong GKC, Mak JSY, Wong A et al (2017) Minimum clinically important difference of Montreal Cognitive Assessment in aneurysmal subarachnoid hemorrhage patients. J Clin Neurosci 46:41–44PubMedCrossRef

637.

Teixeira C, Rosa RG (2018) Post-intensive care outpatient clinic: is it feasible and effective? A literature review. Rev Bras Ter Intensiva 30(1):98–111PubMedPubMedCentralCrossRef

638.

Cuthbertson BH, Rattray J, Campbell MK et al (2009) The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial. BMJ 339:b3723PubMedPubMedCentralCrossRef

639.

Jensen JF, Egerod I, Bestle MH et al (2016) A recovery program to improve quality of life, sense of coherence and psychological health in ICU survivors: a multicenter randomized controlled trial, the RAPIT study. Intensive Care Med 42(11):1733–1743PubMedCrossRef

640.

Schofield-Robinson OJ, Lewis SR, Smith AF et al (2018) Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors. Cochrane Database Syst Rev 11:CD012701PubMed

641.

Kowalkowski M, Chou SH, McWilliams A et al (2019) Structured, proactive care coordination versus usual care for Improving Morbidity during Post-Acute Care Transitions for Sepsis (IMPACTS): a pragmatic, randomized controlled trial. Trials 20(1):660PubMedPubMedCentralCrossRef

642.

Paratz JD, Kenardy J, Mitchell G et al (2014) IMPOSE (IMProving Outcomes after Sepsis)-the effect of a multidisciplinary follow-up service on health-related quality of life in patients postsepsis syndromes-a double-blinded randomised controlled trial: protocol. BMJ Open 4(5):e004966PubMedPubMedCentralCrossRef

643.

Prescott HC, Iwashyna TJ, Blackwood B et al (2019) Understanding and enhancing sepsis survivorship. Priorities for research and practice. Am J Respir Crit Care Med 200(8):972–981PubMedPubMedCentralCrossRef

644.

Batterham AM, Bonner S, Wright J et al (2014) Effect of supervised aerobic exercise rehabilitation on physical fitness and quality-of-life in survivors of critical illness: an exploratory minimized controlled trial (PIX study). Br J Anaesth 113:130–137PubMedPubMedCentralCrossRef

645.

Battle C, James K, Temblett P et al (2019) Supervised exercise rehabilitation in survivors of critical illness: a randomised controlled trial. J Intensive Care Soc 20(1):18–26PubMedCrossRef

646.

Connolly B, Thompson A, Douiri A et al (2015) Exercise-based rehabilitation after hospital discharge for survivors of critical illness with intensive care unit-acquired weakness: a pilot feasibility trial. J Crit Care 30(3):589–598PubMedPubMedCentralCrossRef

647.

Jones C, Skirrow P, Griffiths RD et al (2003) Rehabilitation after critical illness: a randomized, controlled trial. Crit Care Med 31:2456–2461PubMedCrossRef

648.

Jones TK, Fuchs BD, Small DS et al (2015) Post-acute care use and hospital readmission after sepsis. Ann Am Thorac Soc 12(6):904–913PubMedPubMedCentralCrossRef

649.

McDowell K, O’Neill B, Blackwood B et al (2017) Effectiveness of an exercise programme on physical function in patients discharged from hospital following critical illness: a randomised controlled trial (the REVIVE trial). Thorax 72(7):594–595PubMedCrossRef

650.

McWilliams DJ, Benington S, Atkinson D (2016) Outpatient-based physical rehabilitation for survivors of prolonged critical illness: a randomized controlled trial. Physiother Theory Pract 32(3):179–190PubMedCrossRef

651.

Walsh TS, Salisbury LG, Merriweather JL et al (2015) Increased hospital-based physical rehabilitation and information provision after intensive care unit discharge: The RECOVER randomized clinical trial. JAMA Intern Med 175:901–910PubMedCrossRef

652.

Health NIf, Excellence C (2014) Rehabilitation after critical illness in adults: NICE Reino Unido; 2014. https://www.nice.org.uk/guidance/qs158/resources/rehabilitation-after-critical-illness-in-adults-pdf-75545546693317. Accessed 17 Mar 2021

653.

Major ME, Kwakman R, Kho ME et al (2016) Surviving critical illness: what is next? An expert consensus statement on physical rehabilitation after hospital discharge. Crit Care 2016 20:354

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

Excerpt

Neu im Fachgebiet AINS

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Hochrisiko-Eingriffe für postoperative Übelkeit

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

Update AINS

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2021

Using the lung ultrasound score to monitor disease progression for COVID-19-associated ARDS

Effect of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi-center stepped wedge cluster-randomized controlled trial

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges

Diagnosis of spontaneous intestinal perforation using point of care ultrasound